Fact-checked by Grok 2 weeks ago

Infection prevention and control

Infection prevention and control () constitutes a set of evidence-based protocols and practices designed to interrupt the transmission of ic microorganisms, thereby safeguarding patients, healthcare personnel, and communities from healthcare-associated and community-acquired infections. Fundamental principles derive from established modes of pathogen spread—, droplet, , and vector-borne—targeted through standard precautions like meticulous hand hygiene, aseptic techniques, and proper use of (PPE), alongside transmission-based precautions tailored to specific pathogens, such as isolation for diseases. Surveillance, , and environmental further underpin effective programs, which have demonstrably curtailed rates, such as central line-associated bloodstream infections and surgical site infections, yielding improved clinical outcomes and economic efficiencies. Notable achievements include multi-decade declines in preventable infections via targeted interventions, though persistent hurdles encompass inconsistent adherence, infrastructural deficits, and adaptive threats from and novel pathogens, prompting ongoing refinements in policy and training.

Historical Development

Pre-Modern Foundations

Early recognition of contagious diseases prompted isolation practices in ancient societies. In the , Mosaic law prescribed the separation of individuals with skin diseases resembling , requiring them to dwell outside camps and announce their uncleanness upon approach, as detailed in Leviticus 13:45-46, practices codified around the 13th century BCE. Similar measures appear in ancient Indian and Chinese texts, where afflicted persons were segregated to prevent spread, reflecting empirical observation of despite lacking germ theory. Ancient civilizations also employed rudimentary hygiene for wound and infection control. physicians washed hands and wounds with mixtures of , , and before procedures, harnessing natural properties empirically. practices, documented in circa 1550 BCE, included cleaning injuries with boiled water, vinegar, and , reducing bacterial load through antiseptics predating formal microbiology. Greek healers like advocated boiling water and wine for wound irrigation, linking cleanliness to recovery rates. The , originating with around 400 BCE, posited diseases arose from polluted air from decaying matter, influencing preventive like street cleaning and avoiding fetid areas, though it conflated environmental factors with true contagion. This framework spurred with herbs and fires during outbreaks, inadvertently limiting airborne spread in enclosed spaces. Medieval Europe formalized quarantine amid the (1347–1351), which killed 30–60% of the population. Venice established isolation protocols by 1377, detaining ships and travelers for 30 days (trentino) on islands like , evolving to 40 days (quaranta) by 1448 to cover incubation. () enacted similar laws in 1377, confining suspects and fining violators, reducing urban mortality through enforced separation. These measures, rooted in trade protection, marked institutional precursors to modern and containment.

20th-Century Formalization

The formalization of infection prevention and control (IPC) in healthcare institutions accelerated in the mid-20th century, driven by post-World War II surges in hospital-acquired infections (HAIs), particularly antibiotic-resistant Staphylococcus aureus. In the United States, widespread staphylococcal outbreaks in nurseries and surgical wards during the 1950s—exacerbated by penicillin overuse—prompted hospitals to establish dedicated surveillance and response mechanisms, marking the shift from ad hoc measures to structured programs. By 1958, the American Hospital Association advocated for infection committees comprising physicians, nurses, and administrators to oversee monitoring, policy development, and outbreak investigations, with early efforts focusing on handwashing reinforcement, aseptic techniques, and patient isolation. Parallel developments occurred in the , where the Service's formation in 1948 highlighted HAIs as a systemic issue, leading to formalized units by the late 1950s. These units emphasized epidemiological tracking of pathogens like methicillin-resistant S. aureus precursors and implemented mandatory reporting of surgical site infections, influencing training for "infection control sisters" (nurses specialized in hygiene oversight). Empirical data from these programs demonstrated reductions in rates through targeted interventions, such as cohorting infected patients and environmental cleaning protocols, underscoring the causal link between and containment. 00184-2/abstract) The U.S. Centers for Disease Control and Prevention (CDC), originally focused on communicable diseases since its 1946 founding as the Communicable Disease Center, pivoted to hospital IPC in the 1960s amid rising HAIs. In 1963, the CDC issued guidelines recommending every hospital appoint an infection control officer and committee, formalizing roles for data-driven practices. This culminated in the 1965 Comprehensive Hospital Infections Project (CHIP), a collaborative surveillance initiative across eight U.S. hospitals that quantified HAI incidence—revealing rates up to 10% in some settings—and validated interventions like barrier precautions, establishing benchmarks for national standards. These efforts prioritized empirical validation over anecdotal hygiene, laying the foundation for evidence-based IPC frameworks.

Post-1970s Advancements and Organizations

The Association for Professionals in Control and Epidemiology (APIC), founded in 1972, marked a pivotal step in professionalizing infection prevention by uniting practitioners to develop education, research, and policy on healthcare-associated infections (HAIs). Concurrently, the Centers for Disease Control and Prevention (CDC) established the National Nosocomial Infections Surveillance (NNIS) system in 1970, enabling systematic tracking of HAIs across U.S. hospitals and informing targeted interventions. The 1976 Study on the Efficacy of Nosocomial Control (SENIC), conducted by the CDC, provided empirical evidence that hospital programs incorporating active surveillance and at least five control measures—such as isolating infected patients and using appropriate barriers—reduced infection rates by about one-third, validating the causal role of structured oversight in curbing transmission. In 1980, the Society for Healthcare Epidemiology of America () was formed to promote scientific research and application of epidemiology in preventing HAIs, fostering collaborations between clinicians and researchers. The 1980s brought advancements driven by the epidemic; in 1985, the CDC issued recommendations for , mandating gloves, gowns, masks, and eye protection during anticipated exposure to blood or certain body fluids from all patients, regardless of perceived infection status, to mitigate bloodborne pathogen risks like and . These guidelines, formalized between 1985 and 1988, shifted practices from category-specific isolation to broader, evidence-based barriers, reducing needlestick injuries and pathogen transmission in healthcare settings. By the 1990s, infection control evolved toward integrated frameworks; the CDC's 1996 Hospital Infection Control Practices Advisory Committee (HICPAC) guidelines merged with body substance isolation into Standard Precautions, applying contact, droplet, and airborne measures universally to interrupt transmission chains. The NNIS system transitioned into the National Healthcare Safety Network (NHSN) in 2005, expanding surveillance to include device-associated infections and enabling real-time data for bundle interventions, such as central line-associated bloodstream infection (CLABSI) protocols that achieved up to 60% reductions in some facilities through checklists and compliance monitoring. The (WHO) advanced global standardization post-2000 via its multimodal strategies, including the 2005 hand hygiene campaign, which emphasized alcohol-based rubs and system-level changes, correlating with improved adherence rates from 20-30% to over 50% in participating hospitals. These developments underscored causal mechanisms like surveillance-driven feedback loops and barrier efficacy, with organizations like APIC and issuing peer-reviewed guidelines that prioritized empirical outcomes over regulatory compliance alone. By the 2010s, emphasis grew on and environmental controls, informed by NHSN data showing HAIs declined 16% in U.S. hospitals from 2008 to 2014 due to bundled practices.

Core Principles and Frameworks

The Chain of Infection Model

The chain of infection model conceptualizes the transmission of infectious diseases as a sequential process involving six interdependent links, any of which can be interrupted to prevent spread. Developed from epidemiological principles, this framework identifies the infectious agent, its reservoir, portal of exit from the reservoir, mode of transmission, portal of entry into a new host, and the susceptibility of the host. The model underscores that infection requires all links to remain intact, enabling targeted interventions in healthcare and public health settings to disrupt transmission dynamics. The infectious agent refers to the capable of causing disease, such as , viruses, fungi, or parasites, with transmissibility influenced by factors like , dose required for , and environmental stability. For instance, difficile spores demonstrate high resistance to disinfectants, complicating control in hospital environments. The is the where the lives, grows, and multiplies, encompassing humans, animals, arthropods, plants, , or inanimate objects; human reservoirs include asymptomatic carriers or clinically ill individuals shedding pathogens. Animal reservoirs, as in zoonotic diseases like from bats or dogs, highlight the need for veterinary to mitigate spillover risks. The portal of exit denotes the site from which the escapes the , typically through respiratory secretions, , urine, blood, or skin lesions; for example, noroviruses exit primarily via fecal-oral routes from vomit or . Control measures target these exits, such as covering coughs to contain droplet spread of . Modes of describe how the travels from the to a new , categorized as direct contact (e.g., touching infected wounds), indirect contact (via fomites like contaminated stethoscopes), droplet (short-range respiratory particles), airborne (long-range aerosols), vector-borne (e.g., mosquitoes transmitting ), or vehicle-borne (food or water). In healthcare, indirect via hands or equipment accounts for up to 80% of hospital-acquired infections, emphasizing barriers like gloves and disinfection. The portal of entry is the route by which the accesses the new host, often mirroring the exit portal, such as mucous membranes, , , or broken ; surgical incisions, for instance, serve as entry points for postoperative infections. Protective strategies include intact barriers and avoiding needlestick injuries, which transmit bloodborne pathogens like in 6-30% of cases without prophylaxis. Finally, the susceptible host is an individual vulnerable to due to factors like age, immune status, underlying conditions, or lack of immunity; immunocompromised patients, such as those undergoing , face heightened risks from opportunistic pathogens. Vaccination and nutritional support enhance host resistance, breaking the chain by reducing susceptibility, as evidenced by thresholds preventing outbreaks when coverage exceeds 95%. This model informs infection prevention by prioritizing interventions at weakest links; for example, hand hygiene disrupts transmission modes, while targets reservoirs and portals. Empirical studies confirm that multimodal approaches addressing multiple links reduce healthcare-associated infections by 30-70% in intensive care units.

Standard versus Transmission-Based Precautions

Standard Precautions constitute the foundational tier of infection prevention in healthcare settings, applied universally to all patients regardless of their presumed infection status. These practices assume that all blood, body fluids (except sweat), secretions, excretions, non-intact skin, and mucous membranes may contain transmissible infectious agents, thereby protecting healthcare workers, patients, and visitors from exposure. Key elements include hand hygiene performed with alcohol-based hand rub or soap and water before and after patient contact and after glove removal; use of (PPE) such as gloves, gowns, surgical masks, and eye protection based on anticipated exposure risks; adherence to respiratory hygiene and cough etiquette; safe handling of sharps to prevent needlestick injuries; sterile techniques for injections and invasive procedures; and proper cleaning and disinfection of patient care equipment and environments. This approach, formalized by the Centers for Disease Control and Prevention (CDC) in its 2007 guideline update but rooted in earlier for pathogens established in 1987 and expanded in 1996, emphasizes to minimize unnecessary PPE use while ensuring consistent application across diverse care scenarios. Transmission-Based Precautions form the second tier, implemented in conjunction with Standard Precautions for patients with known or suspected infections or colonization by pathogens transmitted through specific routes: contact, droplet, or airborne mechanisms. These additional measures target epidemiologically important organisms where standard practices alone are insufficient to interrupt transmission chains, as determined by clinical syndromes, diagnostic testing, or outbreak data. Contact Precautions involve donning gloves and gowns for all patient interactions to prevent direct (skin-to-skin) or indirect (via fomites) spread, as seen with like methicillin-resistant Staphylococcus aureus (MRSA) or Clostridium difficile; dedicated equipment and enhanced environmental cleaning are also required. Droplet Precautions address large-particle aerosols generated by coughing or sneezing, necessitating a within 3 feet (1 meter) of the patient and spatial separation, applicable to illnesses like or pertussis. Airborne Precautions mandate N95 respirators or equivalents, airborne infection isolation rooms with negative pressure and 6-12 air changes per hour, and restricted movement for pathogens such as or . Duration typically aligns with resolution of symptoms or negative tests, with empirical initiation pending diagnostics. The distinction lies in scope and specificity: Standard Precautions provide a baseline barrier against ubiquitous risks through broad, evidence-derived behaviors supported by randomized trials on hand efficacy (e.g., reducing nosocomial infections by 16-30% in meta-analyses) and observational data on PPE compliance, whereas Transmission-Based Precautions add targeted interventions calibrated to biology and transmission dynamics, justified by outbreak investigations showing containment failures without them, such as SARS-CoV-2 clusters in unisolated cases. Over-reliance on Transmission-Based without Standard foundations risks gaps, as evidenced by persistent healthcare-associated infections (e.g., 4% of U.S. hospitalizations per CDC estimates), underscoring the hierarchical integration where empirical dictates escalation.
FeatureStandard PrecautionsTransmission-Based Precautions
Patient ApplicabilityAll patients, irrespective of infection statusPatients with suspected/confirmed transmissible pathogens (contact, droplet, or airborne)
Core MeasuresHand hygiene, PPE per risk, safe injections, environmental cleaningAdditional to Standard: e.g., gowns/gloves (contact), masks/distance (droplet), N95/rooms (airborne)
RationaleUniversal protection from unrecognized sources; prevents bloodborne/body fluid risksInterrupts specific routes for high-risk pathogens; based on mode of spread
Evidence BaseBroad trials (e.g., hand hygiene meta-analyses); 1996 CDC expansion from UniversalOutbreak data (e.g., TB control via isolation); 2007 HICPAC/CDC guidelines
DurationOngoing for all careUntil clinical/microbiologic resolution or risk abates
This two-tiered framework, endorsed by both CDC and WHO since the early 2000s with reaffirmations in 2022-2024 amid pandemics, balances against transmission risks, though compliance audits reveal persistent challenges like inconsistent PPE donning, contributing to 20-40% preventable infections in surveillance data.

Multimodal Intervention Strategies

Multimodal intervention strategies in infection prevention and control () combine multiple, synergistic measures targeting behavioral, environmental, organizational, and systemic barriers to transmission, rather than relying on isolated actions. These strategies are endorsed by the (WHO) as a core component of effective programs, emphasizing their role in translating evidence-based guidelines into sustained practice improvements to reduce healthcare-associated infections (HAIs) and (). Unlike single interventions, which often yield temporary or limited effects due to unaddressed multifaceted causes of non-compliance—such as resource shortages, knowledge gaps, and cultural norms—multimodal approaches leverage reciprocal reinforcement among components to achieve higher adherence and measurable outcomes. The standard framework, as outlined in WHO guidelines, comprises five key elements: (1) system change, ensuring availability of necessary infrastructure like alcohol-based hand rubs or ; (2) training and education to build knowledge and skills; (3) evaluation and feedback through audits and performance metrics; (4) reminders in the workplace, such as visual cues or protocols; and (5) promotion of an institutional safety climate via leadership commitment and multidisciplinary involvement. This structure has been adapted across domains, including hand hygiene, where WHO's strategy improved compliance from baseline rates often below 40% to over 60% in global trials involving diverse healthcare settings. Empirical evidence from systematic reviews confirms the efficacy of these strategies in reducing HAIs. For instance, a 2024 update of facility-level interventions found that most evaluated programs significantly lowered HAI rates and boosted hand compliance, with effects attributed to addressing root causes like poor and inconsistent protocols rather than isolated fixes. In dialysis units, a bundle incorporating , hand audits with feedback, and staff training reduced bloodstream infections by 45% over 12 months compared to pre-intervention baselines. Similarly, for environmental , efforts combining staff education, product optimization, and monitoring protocols decreased surface and HAI incidence in wards, outperforming standard alone by targeting persistent reservoirs. Applications extend to device-related prevention, such as catheter-associated urinary tract infections, where bundles integrating checklists, , and have reduced rates by up to 50% in randomized studies, demonstrating causal links through pre-post incidence drops uncorrelated with seasonal variations. Sustainability requires ongoing leadership and adaptation, as initial gains can wane without reinforcement; however, resource-limited settings, including low-income countries, have achieved durable improvements via scalable WHO tools, with compliance sustained at 70-80% two years post-implementation in some cohorts. Overall, these strategies prioritize causal realism by intervening at transmission chain nodes—infectious agent, , portal of exit, mode, portal of entry, and susceptible —yielding compounded risk reductions verifiable through incidence metrics rather than proxy measures.

Primary Prevention Methods

Hand Hygiene Protocols

Hand hygiene protocols constitute a of infection prevention and control, targeting the removal or inactivation of transient microorganisms on hands, which serve as the primary for healthcare-associated . Empirical evidence from multimodal interventions demonstrates that improved hand compliance reduces hospital-acquired infection (HAI) rates by 30-50%, with meta-analyses confirming significant decreases in overall HAIs and specific pathogens like methicillin-resistant Staphylococcus aureus. These protocols emphasize timely application over mere frequency, as hands can acquire pathogens during routine patient care activities, facilitating cross-contamination if not addressed. The (WHO) delineates the "My Five Moments for Hand Hygiene" framework to standardize indications for cleaning hands in healthcare settings, focusing on critical points to protect patients, healthcare workers, and surroundings:
  • Before touching a patient: To protect the patient from harmful germs carried on the worker's hands.
  • Before clean/aseptic procedures: To protect the patient against germs, including the worker's own, during invasive or risk-prone tasks.
  • After body fluid exposure risk: To protect the worker and from contaminated hands.
  • After touching a patient: To protect the and worker from the patient's germs.
  • After touching patient surroundings: To protect the worker and subsequent patients from germs persisting on surfaces.
This model, implemented globally since 2009, aligns with causal transmission dynamics by interrupting the chain at hand-contact junctures, though direct experimental validation of its precise structure remains limited compared to observational studies. Techniques prioritize alcohol-based hand rubs (ABHRs) containing 60-95% for routine use when hands are not visibly soiled, as they achieve rapid microbial log reductions (3.2-5.8 log10 CFU in 15-30 seconds) superior to -and- washing (1.8-2.8 log10 CFU), while promoting higher due to speed and accessibility. Application involves dispensing sufficient product to cover all hand surfaces, rubbing palms, backs, fingers, thumbs, and fingertips until dry (typically 20 seconds). Handwashing with plain or antimicrobial and is mandated for visibly soiled hands, after caring for patients with Clostridium difficile or (due to ABHR inefficacy against spores and certain non-enveloped viruses), or when exposure to non-intact skin occurs. The washing sequence includes wetting hands with running , applying , lathering for at least 20 seconds (covering all surfaces, including under nails), rinsing, and drying with a disposable used to turn off the faucet. Surgical hand antisepsis employs stronger formulations, such as gluconate or scrubs followed by alcohol rubs, reducing resident flora for procedures lasting over two hours, per CDC recommendations updated in 2002 and reaffirmed in subsequent reviews. Protocols also incorporate environmental factors, like ensuring ABHR dispensers are accessible within arm's reach and monitoring product efficacy against local resistance patterns, to sustain effectiveness amid variable compliance rates often below 50% in observational audits.

Cleaning, Disinfection, and Sterilization Techniques

Cleaning removes visible organic and inorganic debris from surfaces and instruments using water, detergents, and mechanical action, serving as the foundational step before disinfection or sterilization, as residual soil can shield microorganisms from subsequent processes. In healthcare settings, manual cleaning involves soaking items in enzymatic detergents followed by scrubbing with brushes, while automated methods include ultrasonic cleaners that use high-frequency sound waves to dislodge contaminants and washer-disinfectors that combine detergent cycles with rinsing. Thorough reduces by up to 99% but does not reliably kill microbes, necessitating follow-up . Disinfection targets the reduction of pathogenic microorganisms on inanimate surfaces to safe levels, excluding bacterial spores in low- and intermediate-level processes, while high-level disinfection eliminates all except high numbers of spores. Chemical methods predominate, including alcohols (e.g., 70% ) for low-level surface disinfection, chlorine-based compounds like (500-5000 ppm) for blood spills, and or orthophthalaldehyde for high-level disinfection of endoscopes, with contact times ranging from 10-45 minutes depending on the agent. Physical disinfection via (e.g., 60-70°C for 30 minutes) applies to heat-tolerant items like certain respiratory equipment, though it is less effective against non-enveloped viruses than chemical alternatives. Efficacy varies by agent concentration, exposure time, and organic load, with EPA-registered hospital-grade disinfectants required for clinical use to ensure virucidal, bactericidal, and fungicidal activity. Sterilization destroys all microbial life, including spores, using physical or chemical means, reserved for critical items that contact sterile tissues or the vascular system. Steam autoclaving under pressure (121-134°C at 15-30 psi for 3-30 minutes) remains the gold standard for heat-resistant instruments due to its rapid penetration and sporicidal efficacy, achieving a sterility assurance level of 10^{-6}. For heat-sensitive devices, low-temperature alternatives include ethylene oxide gas (EtO) sterilization (29-60°C with 12-18 hour cycles, though carcinogenic residues limit its use), hydrogen peroxide gas plasma (45-55°C in vacuum chambers for 45-75 minutes), and ionizing radiation like gamma rays from cobalt-60 for pre-packaged disposables, which penetrates but may degrade polymers. Liquid chemical sterilants such as peracetic acid offer rapid cycles (12-30 minutes) for endoscopes but require post-process rinsing to avoid toxicity. Central processing departments in hospitals centralize these practices to minimize errors, with biological indicators (e.g., Geobacillus stearothermophilus spores) verifying efficacy per cycle.

Personal Protective Equipment Usage

Personal protective equipment (PPE) in infection prevention and control consists of barriers such as gloves, gowns, face masks, respirators, and designed to shield healthcare workers from exposure to infectious agents transmitted through , droplet, or routes. Usage is guided by risk assessments aligned with standard and transmission-based precautions, requiring PPE selection based on anticipated modes. For precautions, gloves and gowns are donned for interactions involving patient or environmental ; droplet precautions add surgical masks and ; airborne precautions mandate N95 or equivalent respirators with fit-testing, alongside full-body coverage. Proper fit, such as seal checks for respirators, is essential to ensure efficacy, as ill-fitting equipment compromises protection. Donning PPE follows a standardized sequence to minimize : perform hand hygiene, then apply (covering torso and wrists), or (with nose bridge adjustment), or face shield, and finally gloves (cuff over wrists). This order prevents outer of inner layers. Doffing reverses the process to avoid self-inoculation—remove gloves first (peeling from inside out), followed by , (rolling inward), and / (by straps, avoiding touch to front), with hand hygiene after each step and at completion. Observers or checklists during procedures reduce errors, as studies indicate doffing poses the highest without . Evidence from meta-analyses confirms PPE's role in reducing healthcare-associated infections, with face masks significantly lowering healthcare worker infection rates during respiratory outbreaks, though gloves and gowns show inconsistent standalone effects without multimodal strategies. A review of post-2016 studies reported up to 85% reduction with proper use, emphasizing and , as suboptimal adherence during the correlated with higher transmission. Limitations include physical discomfort leading to non-compliance and incomplete protection against all exposure routes, necessitating integration with hand hygiene and environmental controls. Regular , auditing, and of certified , such as FDA-cleared N95s, are critical for sustained effectiveness.

Environmental and Technological Controls

Antimicrobial Surfaces and Materials

Antimicrobial surfaces and materials incorporate agents such as , silver, or photocatalytic compounds into coatings, fabrics, or solid substrates to actively inhibit or kill microorganisms upon contact, thereby reducing on high-touch environmental surfaces in healthcare settings. These technologies aim to complement, rather than replace, routine cleaning and hand protocols by providing passive, continuous action. Common applications include door handles, bed rails, countertops, and textiles, where microbial persistence contributes to healthcare-associated infections (HAIs). Copper-based surfaces have demonstrated antimicrobial efficacy in multiple studies, rapidly inactivating bacteria like Enterococcus spp., , and Gram-negative pathogens through mechanisms involving and membrane damage. In healthcare facilities, copper-impregnated objects on high-touch surfaces reduced microbial contamination levels, with one study reporting lower in patient rooms compared to non-copper controls. A of copper interventions found that two-thirds of trials showed decreased microbial burden, though evidence for direct HAI reduction remains modest and of low quality, with one estimating a potential 27% decrease in HAIs from copper-treated hard surfaces and linens. settings have reported up to 79% reduction in surface microbial load using copper alloys versus standard materials, measured via ATP . Silver-based coatings, often in nanoparticle or impregnated forms, similarly disrupt bacterial cell walls and inhibit biofilm formation, showing effectiveness against hospital pathogens including multidrug-resistant strains. A silver-impregnated applied to surfaces sustained reduced recovery of pathogens like difficile and over 12 months in clinical trials. Nanosilver combined with other agents in surface coatings achieved long-term bacterial burden reduction on hospital surfaces, bridging gaps in routine disinfection efficacy. However, silver's activity can diminish over time due to wear or environmental factors, necessitating periodic reapplication. Despite these benefits, antimicrobial surfaces do not eliminate the need for standard infection prevention measures, as evidence linking surface bioburden reductions to clinically meaningful HAI decreases is inconsistent and often lacks randomized controlled trials with patient outcomes. A review of antimicrobials in hospital furnishings concluded no high-quality data supports their addition providing value beyond enhanced cleaning protocols alone. Potential drawbacks include cost, regulatory concerns over leaching of agents like silver nanoparticles into the environment, and incomplete efficacy against all pathogens, particularly non-bacterial microbes like viruses or fungi unless specifically engineered. Ongoing research emphasizes multimodal strategies integrating these materials with surveillance and hygiene to maximize impact. Device-related infections, also known as device-associated healthcare-associated infections (HAIs), primarily encompass central line-associated bloodstream infections (CLABSIs), catheter-associated urinary tract infections (CAUTIs), and ventilator-associated pneumonias (VAPs), which arise from breaches in the skin or mucosal barriers by invasive medical devices. These infections account for a substantial portion of HAIs, with estimates indicating that 65-70% of CLABSIs and CAUTIs are preventable through adherence to evidence-based protocols. In U.S. hospitals, device-associated HAIs contribute to overall HAI , where approximately one in 31 patients has at least one HAI on any given day, though targeted interventions have reduced national rates by up to 50% since 2008 benchmarks. Prevention hinges on bundles—sets of concurrent, evidence-based interventions that, when implemented reliably, yield synergistic reductions in rates beyond isolated measures. Core principles include minimizing device use to essential indications, employing aseptic insertion techniques, ensuring meticulous maintenance to prevent , and prompting daily assessments for removal. For intravascular devices, maximal sterile barrier (MSB) precautions during insertion—comprising sterile gown, gloves, cap, mask, and full-body draping—combined with gluconate (CHG) skin antisepsis (2% concentration, applied for at least 30 seconds and allowed to dry), have demonstrated up to 80% risk reduction in CLABSIs. Optimal favors subclavian veins over femoral for non-tunneled catheters in adults to lower risk, while guidance enhances insertion success and reduces mechanical complications.
  • CLABSI Prevention Bundle Elements (per CDC and /IDSA guidelines):
For , appropriate indications are limited to acute , precise output monitoring, or needs, with alternatives like intermittent catheterization preferred when feasible to avert prolonged dwell times, a primary . Aseptic insertion using sterile equipment, securing the catheter to minimize traction and meatal , and maintaining a closed system reduce CAUTI incidence by interrupting bacterial ascension. Daily perineal and avoidance of routine prophylaxis are emphasized, as bundle adherence has halved rates in implementation studies. VAP prevention bundles target oral and airway , incorporating semi-upright positioning (30-45 degrees), daily interruptions of with spontaneous breathing trials, and chlorhexidine-based oral care to curb proliferation in ventilated patients. Subglottic via specialized endotracheal tubes further mitigates microaspiration, with meta-analyses confirming 20-50% VAP reductions from comprehensive bundle application. WHO guidelines for intravascular devices reinforce these by advocating standardized protocols for peripherally inserted catheters, including prompt site assessment for or and replacement only upon malfunction rather than routinely. Technological adjuncts, such as antimicrobial-coated devices (e.g., silver-alloy urinary catheters or minocycline-rifampin central lines), provide marginal benefits in high-risk settings but are not substitutes for bundle , as cost-effectiveness varies and overuse risks emergence. Surveillance via standardized metrics like device-days per 1,000 patient-days enables benchmarking, with facilities achieving >95% bundle adherence correlating to near-elimination of CLABSIs in zero-tolerance programs. Overall, causal pathways trace infections to formation and luminal/extraluminal contamination, underscoring the primacy of mechanical barriers and procedural rigor over adjunctive antimicrobials.

Ventilation and Isolation Practices

Ventilation systems in healthcare facilities dilute and remove airborne pathogens, reducing the risk of transmission for diseases such as and . Guidelines recommend a minimum of 6 (ACH) in existing airborne infection rooms (AIIRs), with 12 ACH required for new constructions to achieve effective particle clearance. Empirical studies demonstrate that increasing ventilation rates lowers airborne infection risk; for instance, each additional unit of ventilation per person correlates with a 12-15% relative risk reduction in transmission in controlled settings. High-efficiency particulate air () filtration and upper-room (UVGI) serve as adjuncts, with UVGI proven to inactivate airborne and viruses beyond mechanical dilution alone. Natural ventilation, via operable windows, can supplement mechanical systems in resource-limited settings, achieving equivalent reductions in cross-infection when airflow exceeds 12 ACH. Isolation practices complement ventilation by physically segregating infectious patients, categorized under transmission-based precautions: , droplet, and . precautions mandate single-patient AIIRs with (at least -2.5 Pa relative to adjacent areas) to prevent contaminant outflow, coupled with exhaust through filters or to the outdoors. For pathogens like varicella or , duration aligns with clinical resolution, such as until rash crusting for or symptom offset plus 21 days for immunocompromised cases. precautions involve dedicated equipment and gowns for multidrug-resistant organisms like MRSA, while droplet measures require masks within 1 meter of patients with . Cohort nursing—grouping similar patients—applies when single rooms are scarce, but evidence indicates higher transmission risks compared to strict . Integration of ventilation and isolation minimizes nosocomial outbreaks; for example, during , AIIR compliance reduced secondary cases by over 90% in modeled scenarios. Monitoring , pressure differentials, and efficiency is essential, as lapses correlate with elevated infection rates in under-ventilated wards. Standards from 170 emphasize directional airflow and to 13 or higher, though real-world efficacy depends on maintenance and viability.

Surveillance and Response Mechanisms

Infection Surveillance Systems

Infection surveillance systems involve the systematic collection, , , and dissemination of regarding healthcare-associated (HAIs) to enable timely detection, prevention, and control measures. These systems track rates, identify emerging threats, and evaluate the impact of interventions, serving as a for reducing HAIs across healthcare settings. By providing standardized metrics such as standardized ratios (SIRs), they allow comparison against baselines, with U.S. national showing SIR reductions for central line-associated bloodstream from a 2015 baseline to 2023. Surveillance methods are broadly categorized as active or passive. Active surveillance entails proactive efforts by trained personnel to identify cases using standardized criteria, such as daily or weekly chart reviews and laboratory , which increases detection rates but requires significant resources. In contrast, passive surveillance relies on voluntary reports from healthcare providers to authorities, which is less resource-intensive but prone to underreporting due to inconsistent and lack of epidemiological among reporters. Active methods have demonstrated superior effectiveness, with studies linking them to a 44% reduction in and notable decreases in urinary tract infections through enhanced early detection. Prominent examples include the U.S. Centers for Disease Control and Prevention's (CDC) National Healthcare Safety Network (NHSN), a secure, internet-based platform launched in 2005 and now the nation's most widely used HAI tracking system, encompassing over 18,000 facilities as of recent reports. NHSN integrates for HAIs, use, and device utilization, enabling facilities to performance, states to monitor regional trends, and policymakers to track national progress, such as the 2023 HAI Progress Report documenting declines in select infections amid disruptions. Internationally, analogous systems like the European Centre for Disease Prevention and Control's networks apply similar principles, though implementation varies by resource availability, with electronic tools increasingly supplementing manual processes to improve accuracy and timeliness. Despite their value, surveillance systems face challenges including data quality inconsistencies, under-detection in passive approaches, and the need for advanced analytics to handle electronic health records integration. electronic surveillance has shown promise in reducing HAIs by automating case identification, as evidenced by implementations that lowered nosocomial infection rates through prompt alerts. Overall, robust correlates with lower HAI incidence when paired with feedback loops to clinicians, underscoring its causal role in prevention rather than mere monitoring.

Outbreak Investigation Procedures

Outbreak investigation procedures in prevention and control () involve a structured epidemiological approach to identify the causative agent, pathways, and risk factors during clusters of infections, enabling rapid implementation of targeted interventions to limit spread, particularly in healthcare settings where vulnerable populations amplify risks. These procedures prioritize multidisciplinary collaboration among infection control teams, epidemiologists, laboratorians, and officials to verify clusters beyond expected endemic rates and distinguish true outbreaks from artifacts like diagnostic changes or enhancements. In healthcare-associated (HAI) contexts, investigations often reveal breaches in standard precautions, contaminated devices, or environmental reservoirs, with CDC providing on-site or remote support via Epi-Aid requests to facilities and health departments. The Centers for Disease Control and Prevention (CDC) outlines a 10-step framework for field investigations of infectious outbreaks, adaptable to IPC scenarios such as nosocomial clusters.
  1. Prepare for field work: Assemble a team with defined roles, secure administrative approvals, coordinate laboratory capacity, and ensure safety protocols including (PPE) tailored to the suspected .
  2. Confirm the diagnosis: Validate cases through patient interviews, clinical examinations, record reviews, and specimen collection for microbiological confirmation, ruling out alternative explanations.
  3. Determine the existence of an outbreak: Compare observed case counts to historical baselines or expected rates from surveillance data, excluding pseudo-outbreaks from lab errors or enhanced reporting.
  4. Identify and count cases: Develop a working case (clinical, lab, epidemiological criteria) and systematically search records, systems, and contacts to compile a case .
  5. Tabulate and orient data by time, place, and person: Construct curves, spot maps, and demographic analyses to identify patterns in onset, location, and affected groups, guiding hypothesis formation.
  6. Develop hypotheses: Formulate explanations for , , and based on descriptive findings, incorporating agent-host-environment interactions.
  7. Test hypotheses epidemiologically: Conduct , case-control, or other analytic studies to assess associations, such as relative risks or odds ratios for exposures like procedures or personnel.
  8. Compare with laboratory and environmental studies: Integrate molecular typing, , or sampling of air, water, or surfaces to corroborate epidemiological data and pinpoint vehicles.
  9. Implement control and prevention measures: Apply immediate interventions like enhanced , , or source removal, refining based on evolving evidence and monitoring via active for effectiveness.
  10. Communicate findings: Disseminate results through internal briefings, reports, and peer-reviewed publications to inform policy, reinforce IPC training, and prevent recurrences.
The (WHO) aligns with this sequence, emphasizing early generic controls (e.g., hand hygiene reinforcement) during verification and iterative refinement of case definitions via line-lists and descriptive analytics before agent-specific actions like . In HAI investigations, often uncovers lapses preventable by adherence to evidence-based protocols, with post-outbreak audits strengthening surveillance integration into .

Quarantine and Isolation Protocols

Quarantine involves separating and restricting the movement of individuals who have potentially been exposed to a but remain , typically for a period equal to the disease's time, to monitor for symptom onset and prevent onward transmission. , by contrast, confines those confirmed or suspected to be infected with a , aiming to limit contact with susceptible persons until they are no longer contagious. These measures form core components of infection prevention and control (IPC), grounded in the causal principle that physical separation interrupts chains, particularly for diseases with person-to-person spread via respiratory droplets, contact, or routes. In healthcare settings, isolation protocols build on standard precautions—such as hand hygiene and use of —with transmission-based additions tailored to the pathogen's mode of spread. Contact precautions require gowns and gloves for direct or indirect contact with patients or environments; droplet precautions mandate surgical masks within 3-6 feet of patients for pathogens like ; and airborne precautions necessitate negative-pressure rooms and N95 respirators for aerosol-generating threats like . Durations are pathogen-specific: for example, isolation lasts until 4 days after rash onset, while contact precautions extend at least 48 hours post-symptom resolution or longer during outbreaks. protocols, often managed at community or border levels, include active symptom monitoring, testing, and support services; for exposures pre-vaccination era, 14-day home was standard, reflecting the virus's median incubation of 5-6 days. Empirical evidence supports efficacy in reducing transmission when implemented rigorously. Modeling from data indicates that case isolation combined with averts more infections than isolation alone, with one study estimating 50-80% reduction in reproductive number (R) under optimal adherence. During the 2014-2016 outbreak, strict isolation of confirmed cases in treatment units, coupled with contact , contributed to containment, lowering incidence by interrupting chains after initial surges exceeding 20,000 cases across . Similarly, in the 2003 outbreak, quarantine of over 18,000 contacts in correlated with rapid decline in cases, though effectiveness hinged on compliance rates above 90%. Shortening quarantine from 10 to 7 days for , with testing, posed minimal added risk in simulations, balancing control with feasibility. Legal frameworks underpin enforcement, with U.S. authority deriving from the and state laws enabling compulsory measures during outbreaks, as invoked for in 2014. Challenges include adherence, with studies showing 20-30% non-compliance in voluntary settings, underscoring the need for enforceable protocols without empirical backing for blanket large-scale absent high transmissibility. In low-resource contexts, such as the 2014 response, units reduced secondary infections by 40-60% through dedicated facilities, but required logistical support to avoid iatrogenic spread. Overall, these protocols' success depends on characteristics, timely detection, and integration with , yielding verifiable reductions in outbreak peaks when R exceeds 1.

Vaccination and Immunization Strategies

Vaccination of Healthcare Workers

Vaccination of healthcare workers (HCWs) serves to mitigate occupational risks of , curb transmission to vulnerable patients, and minimize absenteeism that could strain healthcare systems. Empirical data indicate that HCWs face elevated exposure to pathogens like (HBV), , and due to frequent patient contact, with unvaccinated personnel contributing to nosocomial outbreaks. For instance, HBV prevents chronic in over 95% of responsive individuals, averting and transmission in high-risk settings. Similarly, annual reduces HCW infections by 88-89% against matched strains and cuts workdays lost by up to 28%. Core recommendations from authorities include universal HBV vaccination for HCWs with potential exposure, achieving seroprotection in 90-95% after a three-dose series, with boosters unnecessary for most due to long-term immunity. Measles-mumps-rubella (MMR) and varicella vaccines ensure immunity against vaccine-preventable diseases, as outbreaks have occurred in facilities with under-vaccinated staff. Tetanus-diphtheria-acellular pertussis (Tdap) is advised to prevent pertussis transmission, particularly to infants. For seasonal , coverage targets exceed 90% via campaigns, though evidence on direct patient protection remains debated; randomized trials show reduced HCW-to-patient spread in some contexts, but cluster-randomized studies in found no significant mortality benefit. vaccination, updated annually, demonstrated 33% effectiveness against emergency visits in 2024-2025, with mandates correlating to lower HCW infection rates and hospital transmission. Mandatory policies have boosted uptake, with coverage rising to over 90% in facilities enforcing them versus 60-70% voluntary rates, without widespread staffing disruptions. mandates similarly increased primary series completion by 10-20% and reduced infections by 20-50% in compliant cohorts, though exemptions for contraindications are standard. Challenges persist, including driven by perceived low personal risk or side effect concerns, with HBV non-response in 5-10% necessitating post- testing. Overall, integrates with infection prevention by lowering reservoirs in high-contact roles, supported by causal links from serological and outbreak data rather than mere correlation.

Broader Vaccination Programs in IPC Contexts

Broader vaccination programs extend infection prevention and control () beyond healthcare workers to encompass of patients, visitors, and community members, aiming to curtail the influx of vaccine-preventable diseases (VPDs) into healthcare facilities and mitigate nosocomial transmission. These efforts leverage population-level immunity to reduce overall , thereby alleviating pressure on systems and complementing direct IPC interventions like and . For example, routine childhood schedules have drastically lowered incidence of diseases such as and pertussis, minimizing their introduction via pediatric admissions or adult carriers, with global averting an estimated 3.5–5 million deaths annually from VPDs including those relevant to healthcare settings. Herd immunity thresholds, typically requiring 80–95% coverage depending on pathogen transmissibility, play a pivotal role in shielding vulnerable hospitalized populations from community-sourced outbreaks. High community rates against , for instance, correlate with fewer hospital admissions for flu-related complications, indirectly curbing nosocomial influenza by limiting viral circulation; modeling indicates that universal healthcare personnel vaccination yields herd effects protecting patients, but broader uptake amplifies this by 43% in scenarios through reduced external exposures. Similarly, pneumococcal conjugate vaccines in at-risk adults and children have decreased invasive pneumococcal disease by up to 75% in vaccinated cohorts, reducing secondary hospital-acquired pneumonias. Patient-specific vaccination during hospitalization represents a targeted IPC strategy, particularly for seasonal respiratory viruses. A retrospective cohort study of over 1,000 hospitalized patients found that reduced the odds of hospital-acquired influenza by approximately 50%, independent of healthcare worker immunization status, highlighting direct protective effects against in-facility transmission. Programs vaccinating elderly or immunocompromised inpatients against influenza and pneumococcus have shown efficacy in preventing VPD exacerbations, with post-discharge community follow-up enhancing sustained immunity. For pertussis, cocooning strategies—vaccinating household contacts and visitors—further integrate into IPC by breaking transmission chains to neonates in neonatal intensive care units. Emerging vaccines targeting common healthcare-associated pathogens, such as or , hold promise for broader IPC integration, though clinical trials indicate challenges in efficacy against colonized strains; current data suggest potential reductions in surgical site infections if administered preoperatively to at-risk surgical patients. Overall, these programs' success hinges on surveillance-linked uptake, with evidence from integrated screening-vaccination models showing decreased infection clusters when community immunity informs protocols. Limitations include variable coverage in low-resource settings and waning immunity necessitating boosters, underscoring the need for ongoing empirical evaluation.

Implementation Barriers and Human Factors

Training and Education in IPC

Training and education in infection prevention and control () are essential for equipping healthcare personnel with the knowledge, skills, and competencies required to implement evidence-based practices that reduce healthcare-associated infections (HAIs). The Centers for Disease Control and Prevention (CDC) identifies education and training of healthcare personnel as one of eight core IPC practices applicable across all healthcare settings, emphasizing the need for initial orientation, ongoing competency assessment, and tailored programs to address specific risks such as multidrug-resistant organisms. Similarly, the (WHO) outlines core competencies for IPC professionals, including , , and education delivery, to ensure standardized expertise in facilities. These efforts target diverse groups, including physicians, nurses, environmental services staff, and administrators, recognizing that lapses in basic practices like hand contribute to 30-50% of preventable HAIs globally. Core curricula typically cover foundational elements such as , , routine precautions, and outbreak response, often delivered through multimodal approaches including e-learning modules, workshops, and simulation-based training. The CDC's STRIVE program, for instance, provides free online courses on HAI prevention, focusing on technical skills like catheter-associated reduction and foundational behaviors such as hand compliance. Competency models from organizations like the Association for Professionals in Infection Control and (APIC) integrate body knowledge (e.g., from the Certification Board of Infection Control and ) with practical standards, requiring demonstration of abilities in data analysis, policy development, and staff training. In , IPAC Canada's framework specifies five foundational competencies—, , routine practices, surveillance, and program management—updated in 2022 to incorporate post-pandemic lessons on aerosol transmission. Ongoing is prioritized, with annual refreshers mandated to counter knowledge decay, as evidenced by pre- and post-training assessments showing sustained gains only with reinforcement. Empirical evidence supports the efficacy of structured in enhancing compliance and reducing rates, though outcomes vary by program design and evaluation rigor. A 2023 modular for medical students in demonstrated significant improvements (from 52% to 78% mean scores) and better practice adherence, correlating with lower simulated HAI risks. In , an integrated package including IPC elevated facility maturity levels and cut central line-associated by 25% over 18 months, per WHO minimum requirements assessments. African facility studies from 2020-2023 further indicate that bundled interventions with boosted hand adherence by 15-40% and reduced HAIs by up to 35%, underscoring causal links via improved al competencies. However, Kirkpatrick-model evaluations of ICU in 2025 revealed persistent gaps in translating to without reinforcement, with only 60-70% retention at six months absent multimodal follow-up. These findings highlight that while yields measurable reductions in HAIs—potentially up to 65% in optimized programs—sustained impact demands integration with and accountability mechanisms.

Compliance Challenges and Behavioral Factors

Compliance with infection prevention and control () protocols among healthcare workers remains suboptimal, with hand hygiene adherence rates typically ranging from 30% to 60% across settings, despite evidence linking higher compliance to reduced healthcare-associated infections. Factors such as high workload and time pressures contribute significantly to lapses, as frontline staff often prioritize patient care over procedural adherence during peak demands. Personal protective equipment (PPE) compliance faces distinct barriers, including inconsistent availability, discomfort from prolonged use, and perceived interference with clinical tasks like patient communication or dexterity. Studies during respiratory outbreaks highlight how doubts about PPE and inadequate sizing or design exacerbate non-adherence, with up to 35% of workers citing unavailability as a primary obstacle. Behavioral factors underpin many compliance shortfalls, rooted in cognitive appraisals of and effort. Healthcare workers frequently underestimate personal risk, leading to habitual shortcuts, while social norms within teams can normalize deviations if not actively countered by leadership reinforcement. Attitudes toward IPC measures, influenced by prior and perceived , determine sustained adherence; for instance, nurses exhibit higher compliance than physicians due to role-specific exposure awareness and routine integration. Interventions targeting these behaviors, such as real-time feedback and environmental cues, have shown modest gains, yet systemic issues like resource shortages in underfunded facilities perpetuate cycles of non-compliance. Knowledge gaps persist despite education efforts, with incomplete understanding of protocols correlating to lower uptake, underscoring the need for tailored, recurrent behavioral nudges over one-off training.

Resource Constraints in Low-Resource Settings

Low-resource settings, typically encompassing low- and middle-income countries (LMICs) and underfunded healthcare facilities in high-income countries, face significant barriers to effective infection prevention and control () due to chronic shortages in financial, material, and human resources. These constraints limit the implementation of basic IPC measures such as hand hygiene infrastructure, (PPE), and sterilization capabilities, exacerbating the transmission of healthcare-associated infections (HAIs). Inadequate funding often results in facilities lacking reliable supplies, , or alcohol-based hand rubs, with global surveys indicating that only 42% of facilities in LMICs had basic hand hygiene services at the point of care as of 2021. shortages compound these issues, as understaffed and undertrained personnel struggle to adhere to protocols amid high loads. Material constraints particularly hinder core IPC practices. For instance, inconsistent availability of PPE during routine operations or outbreaks forces reliance on suboptimal alternatives, increasing exposure risks for healthcare workers. Sterilization equipment and single-use supplies are often scarce, leading to improvised methods that may not fully eliminate pathogens, while the absence of functional laboratories impedes microbial and susceptibility testing. Infrastructure deficits, including and poor , further facilitate and contact transmission, as seen in settings where isolation rooms are nonexistent or shared. These limitations are not merely logistical but causally linked to elevated HAI rates, with empirical data showing prevalence in LMICs ranging from 5.7% to 19.1%, compared to 4-6% in high-income countries. Recent WHO assessments confirm that patients in LMICs face up to 20 times higher risk of acquiring HAIs than in high-income settings. The disproportionate HAI burden in resource-constrained environments stems from both direct resource gaps and indirect factors like inconsistent , which underestimates true incidence due to limited diagnostic capacity. In intensive care units, HAI rates can reach 30% overall but are 2 to 20 times higher in LMICs, driven by deficiencies in trained control teams and guideline adherence. Political instability and fixed budgets further restrict investment in scalable solutions, such as low-cost IPC bundles prioritizing hand and aseptic techniques, which have shown feasibility but require sustained external support for implementation. Data scarcity persists, with many LMICs lacking robust epidemiological reporting, potentially masking even higher transmission rates and complicating targeted interventions. Adaptations in low-resource contexts emphasize pragmatic, context-specific strategies, including community-based training and reusable equipment protocols, yet systemic underfunding perpetuates cycles of vulnerability. Peer-reviewed analyses highlight that without addressing root causes like deficits and education, programs falter, as evidenced by stalled progress post-COVID-19 despite heightened awareness. aid and WHO-guided minimal packages offer partial , but local ownership remains challenged by competing health priorities and economic pressures.

Evidence Base and Effectiveness

Empirical Data on Healthcare-Associated Infection Reduction

Multimodal interventions, including hand promotion and device care bundles, have demonstrated measurable reductions in healthcare-associated infections (HAIs) through prospective studies and national surveillance. A of interventions, emphasizing hand and personal protective equipment use, reported a 35% reduction in HAIs with an of 0.65 (95% CI: 0.54–0.79). The estimates that comprehensive programs, incorporating hand , can reduce HAIs by 35-70% across healthcare settings, based on aggregated evidence from implementation trials. Hand directly correlates with HAI incidence, with observational and interventional data showing inverse relationships. In a care study, increasing hand from 59% to 71% corresponded to substantial HAI rate declines, underscoring the causal link via reduced . A three-year observational linked a 10% improvement in hand to a 6% overall HAI reduction, independent of other factors. Exceeding high thresholds (>90%) in a -wide program yielded statistically significant HAI decreases (p=0.0066), with 197 fewer infections over the study period. Device-associated HAIs have declined markedly with bundle interventions, which standardize insertion, maintenance, and removal protocols. Central line-associated bloodstream infection (CLABSI) bundles, including skin antisepsis and daily line necessity reviews, have achieved near-zero rates in high-compliance settings, sustained over years in intensive care units. bundle implementations reduced CLABSI incidence by up to 70% in randomized and quasi-experimental trials, with compliance as the key mediator. Similar catheter-associated (CAUTI) bundles, focusing on aseptic insertion and timely removal, have shown 20-50% reductions in prospective cohorts. National U.S. surveillance via the CDC's National Healthcare Safety Network tracks HAI trends using standardized infection ratios (), comparing observed to predicted infections adjusted for risk factors. From 2015 baselines (SIR=1.0), acute care hospitals achieved SIRs below 1.0 for multiple HAIs by 2023, reflecting cumulative IPC impacts despite pandemic disruptions.
HAI Type2022-2023 National SIR Change (Acute Care Hospitals)Key Location-Specific Reductions
CLABSI-13%ICU: -20%; NICU: -13%; Wards: -8%
CAUTI-11%ICU: -16%; Wards: -8%
VAE-5%ICU: -5%
MRSA Bacteremia-16%N/A
C. difficile-13%N/A
These 2023 improvements follow post-2020 rebounds, with CAUTI, MRSA, and C. difficile SIRs falling below 2019 pre-pandemic levels, attributable to renewed bundle adherence and surveillance. Overall, 49 states improved on at least three HAI metrics versus 2015, with 20 states advancing on five or more.

Cost-Benefit Analyses of IPC Measures

Cost-benefit analyses of infection prevention and control () measures typically reveal net economic advantages in healthcare settings, as healthcare-associated infections (HAIs) impose substantial direct costs—estimated at $28.4 to $45 billion annually in the United States alone—through extended stays, additional treatments, and mortality risks—while effective interventions avert these expenses at relatively low marginal costs. Systematic reviews of economic evaluations confirm that core practices, such as hand hygiene and environmental cleaning, frequently demonstrate cost savings exceeding implementation expenses, with returns on investment ranging from $7 to $18 per spent depending on the setting and discount rates applied. These analyses prioritize metrics like incremental cost-effectiveness ratios (ICERs), often showing strategies falling below willingness-to-pay thresholds (e.g., $50,000 per gained in high-income contexts), though results hinge on accurate attribution of HAI reductions to specific measures.00877-5/abstract) Hand hygiene programs exemplify favorable cost-benefit profiles, with multimodal campaigns—incorporating alcohol-based rubs, education, and monitoring—preventing up to 50% of avoidable HAIs and yielding savings of approximately $16.50 in healthcare expenditures per dollar invested, according to assessments grounded in global trial data. A Canadian study quantified this further, estimating net annual savings of $252,847 from hand hygiene adherence improvements, driven by reduced HAI incidence and associated treatment costs, with a benefit-cost of 9.3:1 to 18.1:1 under varying discount rates. In neonatal intensive care units, alcohol handrub protocols for bloodstream prevention proved dominant—both more effective and less costly than soap-and-water alternatives—averting infections at an incremental cost of under $100 per prevented case in resource-constrained environments. Prevention bundles, combining elements like catheter care, chlorhexidine gluconate use, and environmental disinfection, consistently outperform single interventions in economic terms; for instance, an Australian environmental cleaning bundle reduced HAIs by enhancing surface decontamination, achieving cost-effectiveness with an ICER below AUD 35,000 per HAI averted and net savings from fewer admissions. Similarly, Clostridioides difficile control strategies, including contact precautions and bleach disinfection bundles, yielded ICERs as low as $1,200 per infection prevented, far below HAI treatment costs exceeding $10,000 per case. In long-term care facilities, core IPC bundles (hand hygiene plus sanitation) generated positive net benefits in 60% of evaluated programs, though effectiveness diminished in under-resourced sites due to incomplete adherence.
IPC MeasureKey FindingSettingSource
Hand Hygiene Campaign$9.3–$18.1 saved per $1 invested ()
Environmental Cleaning BundleICER < AUD 35,000 per HAI averted; net savings ()
C. difficile Prevention Bundles$1,200 per infection prevented (US modeling)
Neonatal Handrub ProtocolDominant (cost-saving and effective)NICU ()
Despite these positives, analyses reveal limitations: many rely on observational data prone to confounding, potentially overestimating benefits by attributing all HAI declines to without isolating causal effects from secular trends or biases, and few incorporate like staff time or opportunity costs of resource diversion. In low-resource settings, upfront investments in bundles may exceed short-term savings if adherence falters, underscoring the need for context-specific modeling; moreover, economic evaluations often undervalue non-monetary harms, such as ergonomic from prolonged PPE use, which could tip marginal interventions into net losses under rigorous causal scrutiny. Umbrella reviews highlight sparse evidence for certain measures, like advanced diagnostics in , where cost-effectiveness remains unproven amid heterogeneous implementation.

Limitations and Gaps in Current Evidence

Much of the evidence supporting infection prevention and control (IPC) measures derives from observational studies and quasi-experimental designs rather than randomized controlled trials (RCTs), owing to ethical concerns about withholding interventions in high-risk healthcare environments and logistical difficulties in randomizing complex hospital systems. This predominance of lower-tier evidence introduces risks of confounding, selection bias, and the Hawthorne effect, where observed improvements in compliance or outcomes may reflect temporary behavioral changes due to monitoring rather than the intervention itself.00768-X/fulltext) A review of 37 IPC guidelines encompassing 1,315 recommendations revealed that only 1.5% were grounded in high-quality evidence such as meta-analyses of RCTs, with the majority relying on expert opinion or non-randomized observational data (levels III-IV).30011-6/abstract) Heterogeneity across studies further complicates synthesis and generalizability, as variations in definitions (e.g., bundled vs. single-component hand protocols), outcome metrics (e.g., differing HAI criteria), and settings (e.g., ICU vs. general wards) hinder meta-analyses and comparative effectiveness research. For instance, while short-term reductions in healthcare-associated infections (HAIs) are reported in cluster-randomized trials of multifaceted interventions, on durability beyond 12-24 months remains sparse, with few studies assessing rates or sustained behavioral adherence post-intervention. Underreporting of HAIs, estimated at 20-50% in many facilities due to inconsistencies, exacerbates this issue, potentially inflating perceived intervention efficacy in pre-post designs. Significant gaps persist in low- and middle-income countries (LMICs), where over 70% of HAIs occur but high-quality data are limited by inadequate , inconsistent , and resource constraints that preclude rigorous . CDC-identified priorities highlight needs for better real-world transmission dynamics modeling, implementation science to explain why evidence-based practices fail in routine care (the "knowing-doing" gap), and of novel risks like emergence from overuse of broad-spectrum IPC bundles. Additionally, cost-effectiveness analyses are underdeveloped for resource-limited contexts, with most studies focused on high-income settings where interventions like advanced PPE or negative-pressure rooms yield uncertain incremental benefits over basic hygiene.00277-8/fulltext) These evidentiary shortcomings underscore the reliance on precautionary principles for many guidelines, potentially leading to over- or under-emphasis on certain measures without robust causal attribution.

Unintended Consequences and Controversies

Positive Unintended Effects from Enhanced Measures

Enhanced infection prevention and control (IPC) measures implemented in healthcare settings to combat , such as universal masking, rigorous hand hygiene, and environmental cleaning, resulted in significant reductions in healthcare-associated respiratory viral infections (HA-RVIs) beyond SARS-CoV-2. A study across multiple hospitals observed a cumulative incidence of HA-RVIs dropping to near zero during the peak implementation period in 2020, compared to typical seasonal rates of 1-5% in prior years, attributing this to the broad-spectrum protective effects of these protocols against , , and other pathogens.30963-9/abstract) These measures also fostered sustained improvements in hand compliance among healthcare personnel. Surveys and observational from 2020 indicated compliance rates exceeding 90% in some facilities, a marked increase from pre-pandemic baselines of 40-60%, driven by heightened and enforcement, with partial persistence noted in follow-up assessments post-peak. Enhanced cleaning protocols similarly reduced Gram-negative bacterial contamination on high-touch surfaces by up to 50% in controlled trials, contributing to lower overall environmental loads and potential spillover benefits for bacterial prevention. In surgical contexts, stricter preoperative and practices correlated with decreased surgical site rates during the , with one reporting a 20-30% in superficial and deep infections among non-COVID procedures, linked to minimized patient and staff . These outcomes highlight how targeted IPC enhancements can yield ancillary gains in curbing diverse microbial threats, though long-term durability depends on ongoing and behavioral reinforcement.30963-9/abstract)

Negative Impacts on Staff and Patients

Prolonged use of (PPE) in infection prevention and control () has been associated with significant physical strain on healthcare staff, including heat stress, , headaches, dizziness, and musculoskeletal discomfort due to restricted movement and weight of gear. A and reported high prevalence rates of these symptoms among staff during extended shifts, with exacerbating and impairing task performance. Additionally, frequent hand with alcohol-based sanitizers contributes to skin dermatitis and in up to 20-30% of nurses, depending on exposure duration. Psychological burdens on staff from stringent IPC protocols include elevated anxiety, , and , particularly intensified during high-transmission periods like the , where infection preventionists reported worsening from workload and fear of exposure. Studies indicate that PPE-induced communication barriers and heighten emotional distress, with one survey finding over 50% of frontline workers experiencing moderate to severe psychological impacts from prolonged wear. Non-compliance risks, driven by these discomforts, further compound stress, as staff balance infection risks against personal tolerability. For patients, isolation precautions under IPC guidelines often lead to adverse outcomes, including increased , anxiety, and feelings of , as evidenced by multiple studies showing higher scores for these conditions compared to non-isolated patients. A confirmed that segregation for infection control reduces interactions, fostering stigmatization and behavioral , which can prolong recovery. Physical repercussions include higher fall risks from restricted and suboptimal , alongside longer hospital lengths of stay (LOS) averaging 1-2 additional days and elevated costs due to precautionary overheads. While some reviews find no significant clinical adverse events overall, the consensus highlights psychological harm as a consistent unintended , potentially worsening overall outcomes in vulnerable populations like the elderly.

Debates on Overreach and Policy Mandates

During the , debates intensified over mandatory policies for healthcare workers, with proponents arguing they were essential to safeguard vulnerable patients in high-risk settings, while critics contended they represented overreach by disregarding natural immunity from prior and the vaccines' limited against transmission post-Omicron variant emergence. In November 2021, the (CMS) issued an interim rule requiring vaccination of staff in facilities receiving Medicare or Medicaid funding, affecting approximately 17 million workers; the U.S. upheld this mandate on January 13, 2022, in a 5-4 decision, affirming CMS's under existing statutes to impose conditions for participation in federal programs. However, implementation led to workforce disruptions, including resignations and terminations of unvaccinated personnel, exacerbating staffing shortages in nursing homes and hospitals; a 2024 found mandates increased vaccination rates but caused notable employment impacts, particularly in under-resourced regions, without clear evidence of proportional reductions in healthcare-associated infections attributable solely to the policy. Masking mandates in healthcare facilities sparked similar contention, as universal requirements implemented from early 2020 demonstrably lowered positivity rates among healthcare workers during peak transmission periods, yet their persistence into low-prevalence phases post-2022 raised questions of proportionality and efficacy. Studies indicated that revoking staff and visitor mask policies in hospitals did not significantly elevate hospital-acquired rates, suggesting diminishing returns in endemic stages where baseline transmission was controlled by other measures like and testing. Critics, including analyses from policy-oriented journals, highlighted non-clinical costs such as impaired physician-patient communication, increased pediatric anxiety, and resource diversion from targeted interventions, arguing that blanket mandates eroded public trust without commensurate empirical gains in control once community incidence fell below critical thresholds. Broader policy mandates, such as extended quarantines and visitor restrictions under infection prevention guidelines, faced scrutiny for potential overreach into , echoing historical tensions seen in mandatory HIV reporting protocols that delayed implementation due to privacy concerns. Legal challenges, including those against the CDC's expansive use of emergency powers, underscored arguments that agencies exceeded statutory bounds, as in the 2021 eviction moratorium ruled unconstitutional for lacking clear congressional authorization. In healthcare contexts, these debates emphasized causal trade-offs: while mandates facilitated short-term compliance surges, evidence from post-mandate analyses revealed mixed outcomes, with staffing deficits and contributing to indirect rises in non-COVID healthcare-associated , prompting calls for risk-stratified approaches over uniform to balance against systemic burdens.

Recent Developments and Emerging Challenges

Advances in Antimicrobial Resistance Control

Antimicrobial stewardship programs (ASPs) have demonstrated substantial effectiveness in curbing AMR by optimizing antibiotic prescribing, with U.S. hospital implementation rising from 47% in 2015 to 74% by 2023, correlating with a 10-20% reduction in broad-spectrum antibiotic use across facilities. These programs employ prospective audit and feedback, pre-authorization for high-risk agents, and de-escalation protocols, yielding decreased resistance rates for pathogens like Clostridium difficile and extended-spectrum beta-lactamase producers without elevating mortality. In intensive care units, systematic reviews confirm ASPs lower multidrug-resistant organism incidence by 15-30% through targeted interventions, underscoring their causal role in preserving antibiotic efficacy via reduced selective pressure. New antibacterial agents approved since 2023 include Emblaveo (aztreonam-avibactam), authorized by the FDA in February 2025 for complicated intra-abdominal infections caused by resistant like metallo-beta-lactamase producers, offering a non-beta-lactam alternative where options are scarce. However, global approvals remain limited; WHO data indicate only 13 new antibiotics marketed since July 2017, with just two introducing novel chemical classes, highlighting persistent innovation gaps despite urgent needs. Bacteriophage therapy has advanced as a precision alternative for multidrug-resistant infections, with over 20 clinical trials registered by February 2025 targeting conditions like exacerbations and burn wounds, showing phage-specific bacterial without disrupting host . Phase II trials in 2024-2025 report success rates of 70-80% in compassionate-use cases for and infections, evading resistance via co-evolutionary dynamics where phages mutate faster than bacterial defenses. Regulatory frameworks, including U.S. NIAID-funded centers launched in 2024, aim to standardize phage banking and preclinical assays, accelerating translation from bench to bedside. Machine learning models have enhanced AMR prediction by analyzing genomic sequences and surveillance data, achieving 85-95% accuracy in forecasting resistance phenotypes for Pseudomonas aeruginosa and other Gram-negatives using explainable algorithms that identify key resistance genes. Integrated with hospital systems, these tools enable real-time susceptibility forecasting from whole-genome data, reducing empirical broad-spectrum prescribing by up to 25% in pilot implementations. Multi-omics approaches combined with AI further predict outbreak risks and novel biomarkers, supporting proactive stewardship in high-burden settings. Despite promise, model generalizability across diverse populations requires validation to avoid overfitting biases inherent in training datasets.

Technological Innovations Post-2020

Following the , ultraviolet-C (UV-C) disinfection robots emerged as a prominent innovation for surface in healthcare settings, automating the delivery of germicidal UV light to reduce loads. These autonomous systems, such as those developed by Xenex and UVD Robots, navigate rooms while emitting UV-C at 254 nm wavelength, achieving log reductions of 2.3 to 5.8 in microbial on surfaces, outperforming manual methods in controlled trials. A 2025 study comparing robotic to manual disinfection against global priority pathogens confirmed robotic UV-C's superior efficacy, eliminating detectable in environments after 5-10 minute cycles, though efficacy depends on line-of-sight exposure and shadowing mitigation via multi-angle emitters. Adoption accelerated post-2020, with deployments in over 400 U.S. s by 2022, correlating with reduced healthcare-associated infections (HAIs) like when integrated into multimodal protocols. Artificial intelligence (AI) systems advanced infection surveillance by enabling and real-time monitoring of HAIs in hospitals. algorithms analyze electronic health records, , and environmental data to forecast outbreak risks with high accuracy, such as detecting or up to 48 hours in advance in intensive care units (ICUs). From 2021 to 2025, AI-driven tools demonstrated AUC scores exceeding 0.85 for HAI prediction in systematic reviews, streamlining surveillance by automating and reducing manual workload, though challenges include data quality dependencies and from incomplete training sets. Integration with (IoT) sensors for continuous environmental tracking, as piloted in European hospitals by 2023, further enhanced proactive interventions, lowering HAI incidence by 15-20% in modeled scenarios. Nanotechnology-based antimicrobial surfaces gained traction for passive infection control, embedding nanoparticles (NPs) like silver or copper oxides into coatings for hospital bedrails, door handles, and textiles to disrupt bacterial cell walls via generation. Post-2020 developments included copper NP-infused paints reducing and biofilms by over 99% in lab tests, with field trials in ICUs showing sustained efficacy for 6-12 months without leaching toxicity. These surfaces complement , addressing contact responsible for 20-40% of HAIs, though remains limited by manufacturing costs and regulatory hurdles for clinical validation. Emerging hybrid approaches, combining NPs with photothermal activation under ambient light, promise broader-spectrum activity against resistant strains like MRSA, as evidenced in 2024 prototypes. Automated monitoring technologies, including electronic hand hygiene compliance systems and location systems (RTLS), proliferated to enforce behavioral IPC adherence. Sensor-equipped dispensers and badge trackers, deployed in U.S. facilities post-2021, increased compliance rates from 40% to 85% by providing instant and , correlating with 30% HAI drops in adopting wards. These innovations leverage networks for granular , enabling causal attribution of lapses to specific staff or zones, yet require institutional buy-in to counter concerns and false positives from environmental interference. Overall, these post-2020 technologies emphasize and data-driven precision, though underscores their role as adjuncts to foundational practices like handwashing, with long-term effectiveness hinging on rigorous, facility-specific validation.

Global Surveillance Updates 2023-2025

In 2023, the (WHO) initiated a global survey in across 150 countries, territories, and areas to evaluate infection prevention and control (IPC) implementation, revealing that while 71% of countries reported active national IPC programs by 2024, only 6% fully met WHO's minimum core components for effective IPC in assessments conducted during 2023-2024. This survey highlighted persistent gaps in surveillance capacity, with many low- and middle-income countries lacking standardized data collection for healthcare-associated infections (HAIs) and (AMR). Concurrently, the WHO's Global Antimicrobial Resistance and Use Surveillance System () expanded participation to 104 countries by the end of 2023, quadrupling from 25 in 2016, enabling more comprehensive tracking of resistance trends through standardized protocols for bacterial isolate reporting. The 2024 WHO Global Report on Infection Prevention and Control, released on November 29, documented ongoing HAI burdens, estimating millions of preventable cases annually linked to inadequate , and introduced a new global action plan and monitoring framework for spanning 2024-2030, approved at the 77th . In Europe, the European Centre for Disease Prevention and Control (ECDC) conducted point prevalence surveys from April-June and September-November 2023, followed by additional periods in 2024, estimating 4.3 million HAIs annually in EU/EEA settings for 2022-2023, with 29.3% classified as infections and over 3% prevalence in facilities during 2023-2024 assessments. These efforts underscored improvements, including enhanced use monitoring, but identified gaps in device-associated infection tracking. In the United States, the Centers for Disease Control and Prevention (CDC) reported via its National Healthcare Safety Network (NHSN) a 15% decline in central line-associated (CLABSIs) and an 11% reduction in catheter-associated urinary tract infections (CAUTIs) in hospitals for 2023 compared to 2022, based on standardized infection ratios from over 4,000 facilities. By 2025, WHO's GLASS report, published October 13, analyzed data from over 23 million bacteriologically confirmed infections across 127 participating countries and territories as of late 2024, finding that one in six bacterial infections exhibited resistance to common antibiotics in 2023, with trends indicating rising multidrug-resistant strains in priority pathogens like Escherichia coli and Staphylococcus aureus. This marked a shift toward integrated global surveillance integrating genomic sequencing for outbreak detection, though data completeness remained below 50% in many regions due to laboratory capacity constraints. ECDC's ongoing AMR surveillance through the European Antimicrobial Resistance Surveillance Network (EARS-Net) reported stable but high resistance rates in invasive infections for 2023, informing targeted IPC interventions. These updates collectively demonstrate incremental advancements in data standardization and coverage, yet emphasize the need for sustained investment to address underreporting in resource-limited settings, where empirical evidence links improved surveillance to 20-30% reductions in HAI incidence.

Policy Standardization and Variations

International Guidelines from WHO and CDC

The (WHO) outlines eight core components for effective infection prevention and control () programmes at national and acute healthcare facility levels, established in guidelines published in 2016 and refined through subsequent assessments. These components include IPC programme establishment, implementation of evidence-based guidelines, education and training, surveillance of healthcare-associated infections, standard precautions, multimodal improvement strategies, monitoring of programme implementation, and procurement of necessary infrastructure and products. WHO emphasizes hand as a cornerstone, recommending alcohol-based hand rubs or and based on the WHO "Five Moments for Hand Hygiene" to reduce transmission risks. In 2023, WHO consolidated COVID-19-related IPC guidance into broader recommendations, reinforcing respiratory , environmental cleaning, and use of (PPE) like masks and gloves when exposure risks are present. The Centers for Disease Control and Prevention (CDC) specifies six core IPC practices applicable across all healthcare settings, updated in April 2024, focusing on administrative, environmental, and clinical measures to minimize infection risks. These encompass leadership commitment to , education and training for healthcare personnel, adherence to standard precautions—including hand hygiene before and after patient , safe injection practices, and PPE use based on anticipated exposure—and environmental with EPA-registered disinfectants. CDC guidelines, informed by the Healthcare Infection Control Practices Advisory (HICPAC) until its disbandment in March 2025, also detail transmission-based precautions: , droplet, and airborne, tailored to modes like requiring N95 respirators for airborne infections such as . Both organizations prioritize strategies combining policy, education, and monitoring, with WHO's framework geared toward global programme building and CDC's toward practical U.S. healthcare delivery, though alignments exist in evidence-based practices like prioritizing hand compliance rates above 80% for efficacy. Variations include WHO's broader emphasis on national surveillance infrastructure versus CDC's detailed outpatient and dental-specific adaptations. Post-2020 updates reflect lessons from pandemics, with both stressing source control and to curb respiratory spread, supported by empirical data showing reduced in compliant settings.

National Implementations and Differences

National implementations of infection prevention and control () vary substantially across countries, reflecting differences in healthcare , resource availability, regulatory frameworks, and prioritization of . High-income nations generally achieve lower healthcare-associated infection (HAI) rates, ranging from 3.5% to 12% of hospitalized patients, compared to up to 30% in low- and middle-income countries (LMICs), where gaps in , , and hinder adherence to core practices like hand and protocols. Globally, approximately 88.6% of countries reported having a national program as of recent surveys, but implementation depth differs, with only 65% actively operational and LMICs showing lower access to dedicated IPC professionals. In the United States, the Centers for Disease Control and Prevention (CDC) enforces standardized core IPC practices across all healthcare settings, emphasizing hand hygiene, (PPE) use, and device-associated infection prevention bundles. The National Healthcare Safety Network (NHSN) enables mandatory HAI reporting, contributing to measurable reductions, such as a 9% decline in central line-associated (CLABSIs) from 2022 to 2023 and an overall HAI rate affecting about 1 in 31 patients daily. State-level variations exist, with some mandating enhanced tracking for , though compliance relies on facility accreditation rather than uniform federal enforcement. The United Kingdom's (NHS) implements IPC through mandatory surveillance and bundle-based interventions, achieving significant declines in methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections via targeted screening, decolonization, and antibiotic stewardship. Hand hygiene compliance, audited via the WHO "five moments" framework, averages above 95% in many trusts, supported by national campaigns, contrasting with earlier rates below 40%. European countries exhibit policy heterogeneity despite European Centre for Disease Prevention and Control (ECDC) harmonization efforts; for instance, the employs a rigorous "search-and-destroy" MRSA policy with universal screening and isolation, yielding prevalence below 1%, while the and report higher rates exceeding 20-40% in some settings due to selective screening approaches. EU/EEA-wide, HAIs affect an estimated 4.3 million patients annually, with infections comprising 25-30% of cases, and national differences in highly resistant microorganism (HRMO) controls—such as variable pre-admission screening—correlate with disparate outcomes. Australia mandates IPC credentialing for professionals and has introduced dedicated IPC nurse leads in residential aged care since 2023, focusing on outbreak response and , with HAI rates aligning closely to other high-income peers through national guidelines from the Australian Commission on Safety and Quality in Health Care. In contrast, LMICs often prioritize foundational IPC amid resource constraints, with WHO assessments revealing lower compliance in isolation facilities and , exacerbating HAI burdens like , which claims 24% of affected patients globally. These disparities underscore the causal role of enforcement and investment, as evidenced by lower MRSA burdens in nations with stringent versus those with reactive measures.

References

  1. [1]
    Infection prevention and control - World Health Organization (WHO)
    Infection prevention and control (IPC) is a practical, evidence-based approach preventing patients and health workers from being harmed by avoidable infections.Section navigation · Progress on infection... · Patient safety · Health Care Readiness
  2. [2]
    Infection Control Basics - CDC
    Jun 12, 2025 · Infection control prevents or stops the spread of infections in healthcare settings.
  3. [3]
    Infection Control - StatPearls - NCBI Bookshelf - NIH
    Aug 9, 2025 · Infection control refers to the policies and procedures implemented to prevent and minimize the spread of infections in hospitals and other ...
  4. [4]
    CDC's Core Infection Prevention and Control Practices for Safe ...
    Apr 12, 2024 · This document concisely describes a core set of infection prevention and control practices that are required in all healthcare settings.
  5. [5]
    Infection prevention and control - World Health Organization (WHO)
    Infection prevention and control (IPC) is a practical, evidence-based approach whose aim is to prevent patients and health workers from being harmed by ...Core components · Surgical site infection · Global action plan and · Hand hygiene
  6. [6]
    Recommendations for change in infection prevention programs and ...
    May 3, 2022 · Fifty years of evolution in infection prevention and control programs have involved significant accomplishments related to clinical practices, ...
  7. [7]
    Infection Prevention and Control: Practical and Educational Advances
    Jul 26, 2022 · Infection prevention and control (IPC) is associated with improved healthcare, better quality of life and cost-effectiveness in disease prevention.
  8. [8]
    Challenges and opportunities for infection prevention and control in ...
    Dec 20, 2021 · We found that inadequate hospital infrastructure, resource and workforce shortages, education of staff, inadequate in-service IPC training and supervision and ...
  9. [9]
    Three critical challenges in infection prevention and control programs
    1. Emerging pathogens and antimicrobial resistance · 2. Healthcare facility resourcing · 3. Surveillance and reporting requirements.
  10. [10]
    The challenges of implementing infection prevention and ...
    Apr 16, 2024 · Absence of mandates and poor organizational structure · Shortage of trained professionals · Scarce resources, supply constraints, and ...
  11. [11]
    A brief history of the development of infectious disease prevention ...
    In order to cope with infectious diseases, human beings began to prevent and control them from a scratch, from vagueness to accuracy, and from superstition to ...
  12. [12]
    Ancient Sumerian physicians were pioneers in the field of medicine ...
    Mar 17, 2025 · Ancient Sumerian doctors had advanced surgical practices that involved washing their hands and the wounds with antiseptic mixes of honey, alcohol, and myrrh.<|separator|>
  13. [13]
    The History of Wound Care - PMC - NIH
    In the 19th century, the antiseptic technique was a major breakthrough. The introduction of antibiotics helped control infections and decrease mortality. In the ...Missing: pre- | Show results with:pre-
  14. [14]
    A Historical Journey Through Medical Sterilization - Ebeam Machine
    Mar 12, 2025 · Greek physicians, including Hippocrates, recommended mixing wine with boiled water and vinegar to treat wounds. These practices demonstrated an ...Missing: pre- | Show results with:pre-
  15. [15]
    Miasmas, mental models and preventive public health
    Oct 12, 2021 · This paper explores some competing mental models of how infectious diseases spread and shows how these models influenced the scientific process.
  16. [16]
    The Origins of Germ Theory, Part 1: Enter Miasma - EOS Surfaces
    May 5, 2021 · The miasma theory centers around the "bad air," miasma, that carries tiny contagious particles, miasmata, which transfer infection between individuals.
  17. [17]
    The concept of quarantine in history: from plague to SARS - PMC
    The term is strictly related to plague and dates back to 1377, when the Rector of the seaport of Ragusa (then belonging to the Venetian Republic) officially ...
  18. [18]
    Lessons from the History of Quarantine, from Plague to Influenza A
    Jan 22, 2013 · The first English quarantine regulations, drawn up in 1663, provided for the confinement (in the Thames estuary) of ships with suspected plague- ...
  19. [19]
    Social Distancing and Quarantine Were Used in Medieval Times to ...
    Mar 25, 2020 · The 30-day period stipulated in the 1377 quarantine order was ... “Regardless of whether there's a plague in Venice, these hospitals ...
  20. [20]
    History of infection prevention and control - PMC - PubMed Central
    The epidemiology and prevention of infection has its roots in a time prior to the understanding of the germ theory of disease.
  21. [21]
    Control of Health-Care--Associated Infections, 1961--2011 - CDC
    Oct 7, 2011 · This report traces the strategic and tactical steps used to bring about a major public health success: the ubiquity of formal established infection control ...
  22. [22]
    Developing an Infection Control Program
    Dec 1, 2000 · Modern hospital infectioncontrol programs first began in the 1950s in England, where the primary focus of theseprograms was to prevent and control hospital- ...Missing: origins | Show results with:origins
  23. [23]
    Brief Modern-Era History of Infection Prevention
    1965 – The Centers for Disease Control and Prevention (CDC) initiates a research project known as the Comprehensive Hospital Infections Project (CHIP). Eight ...
  24. [24]
    History - APIC
    APIC was founded in 1972 by a pioneering group of infection control nurses who recognized the need for an organized approach to preventing healthcare ...
  25. [25]
    Society for Healthcare Epidemiology of America (SHEA) - LinkedIn
    The Society for Healthcare Epidemiology of America (SHEA) was founded in 1980 to advance the application of the science of healthcare epidemiology.
  26. [26]
    Universal Precautions for Prevention of Transmission of Human ...
    In 1983, CDC published a document entitled "Guideline for Isolation Precautions in Hospitals" (2) that contained a section entitled "Blood and Body Fluid ...
  27. [27]
    Universal Precautions - StatPearls - NCBI Bookshelf - NIH
    Aug 2, 2025 · Universal precautions were introduced by the Centers for Disease Control and Prevention (CDC) in 1985 in response to the HIV epidemic.Missing: 1980s | Show results with:1980s
  28. [28]
    Appendix A: Table 1. History of Guidelines for Isolation Precautions ...
    Nov 27, 2023 · 1985-88 · Universal Precautions. Developed in response to HIV/AIDS epidemic; Dictated application of Blood and Body Fluid precautions to all ...Missing: 1980s | Show results with:1980s
  29. [29]
    The practice of infection control and applied epidemiology
    The Association for Practitioners in Infection Control, Inc. (APIC), a multidisciplinary organization, was established in 1972 to meet the education and ...
  30. [30]
    Chain of Infection Components - CDC
    The chain of components has six sections. They include: Microorganisms: Disease producing, also called pathogens. Virus, parasite, fungus, bacterium ...
  31. [31]
    Chapter 4: Adhere to Principles of Infection Control - Nursing Assistant
    The links in the chain of infection include Infectious Agent, Reservoir, Portal of Exit, Mode of Transmission, Portal of Entry, and Susceptible Host[2]:.<|separator|>
  32. [32]
    Principles of Infectious Diseases: Transmission, Diagnosis ...
    A thorough understanding of the chain of infection is crucial for the prevention and control of any infectious disease, as breaking a link anywhere along the ...
  33. [33]
    The Concept of Chain of Infection and Infection Control Principles
    This process is called the chain of infection, which consists of six links: Causative agent; Infectious reservoir; Path of exit; Mode of transmission; Path of ...
  34. [34]
    Principles of Epidemiology | Lesson 1 - Section 10 - CDC Archive
    After studying this information, outline the chain of infection by identifying the reservoir(s), portal(s) of exit, mode(s) of transmission, portal(s) of entry ...
  35. [35]
    Standard Precautions for All Patient Care | Infection Control - CDC
    Apr 3, 2024 · Standard Precautions are used for all patient care. They're based on a risk assessment and make use of common sense practices and personal protective equipment ...Transmission-Based Precautions · Clinical Safety: Hand Hygiene... · Clinical Safety
  36. [36]
    Standard precautions for the prevention and control of infections
    Jun 20, 2022 · Standard precautions aim to protect both health workers and patients by reducing the risk of transmission of microorganisms from both recognized and ...
  37. [37]
    III. Precautions to Prevent Transmission of Infectious Agents - CDC
    Nov 22, 2023 · There are two tiers of HICPAC/CDC precautions to prevent transmission of infectious agents, Standard Precautions and Transmission-Based Precautions.
  38. [38]
    Transmission-Based Precautions | Infection Control - CDC
    Transmission-Based Precautions are the second tier of basic infection control and are to be used in addition to Standard Precautions for patients who may be ...
  39. [39]
    Transmission-based precautions for the prevention and control of ...
    Jun 20, 2022 · Transmission-based precautions (TBP) are used in addition to standard precautions for patients with known or suspected infection or colonization with ...
  40. [40]
    [PDF] Personal Protective Equipment (PPE) 102 - CDC
    This module will discuss. Transmission-Based Precautions, which are infection prevention measures taken in addition to Standard Precautions to prevent the ...
  41. [41]
    Infection Control Basics - CDC
    Apr 3, 2024 · Transmission-based precautions are used when patients already have confirmed or suspected infections...
  42. [42]
    Infection prevention and control in the context of COVID-19
    Dec 21, 2023 · Updated recommendations for health-care facilities include a focus on the hierarchy of control measures, standard and transmission-based ...<|separator|>
  43. [43]
    Appendix A | Infection Control - CDC
    A Transmission-Based Precautions category was assigned if there was strong evidence for person-to-person transmission via droplet, contact, or airborne routes ...<|separator|>
  44. [44]
    [PDF] WHO multimodal improvement strategy
    Multimodal implementation strategies are a core component of effective infection prevention and control (IPC) programmes according to the WHO Guidelines on Core.
  45. [45]
    Multimodal strategies for the implementation of infection prevention ...
    Objectives: To update the systematic review on facility level infection prevention and control interventions on the WHO core component of using multimodal ...
  46. [46]
    A guide to the implementation of the WHO multimodal hand hygiene ...
    A guide to the implementation of the WHO multimodal hand hygiene improvement strategy. Download (465.1 kB)
  47. [47]
    Global implementation of WHO's multimodal strategy ... - The Lancet
    Aug 23, 2013 · The intervention was associated with a significant improvement of hand-hygiene compliance in all sites, across all professional categories, and ...
  48. [48]
    Effect of a multimodal prevention strategy on dialysis-associated ...
    Feb 2, 2024 · The multimodal prevention strategy consisted of infection surveillance and hand hygiene (HH) compliance observation with active feedback and ...Outcomes · Dialysis-Associated... · Hand Hygiene Compliance<|separator|>
  49. [49]
    Multimodal environmental cleaning strategies to prevent healthcare ...
    Aug 23, 2023 · One strategy to prevent and control infection is environmental cleaning. There are many aspects to an environmental cleaning strategy. We ...
  50. [50]
    Implementation Strategies for Preventing Healthcare-Associated ...
    Many studies have demonstrated that IPC programs by the WHO multimodal strategy have effectively reduced the occurrence of HAIs by improving hand-hygiene ...
  51. [51]
    Effectiveness and sustainability of the WHO multimodal hand ...
    Feb 17, 2022 · The WHO HH improvement strategy is an effective and pandemic-adaptable method to sustainably increase HH compliance in resource limited settings ...
  52. [52]
    Multimodal Approach to Implement Infection Prevention and Control ...
    Oct 15, 2024 · Interventions using a multimodal approach have a positive effect in improving compliance and preventing infections.
  53. [53]
    The Effectiveness of Interventions in Improving Hand Hygiene ... - NIH
    Jul 17, 2021 · The aim of this meta-analysis is to determine the most effective interventions to improve hand hygiene and to develop a logic model based on the ...
  54. [54]
    Reduction of Healthcare-Associated Infections by Exceeding High ...
    Aug 16, 2016 · We investigated whether an improvement in hand hygiene compliance from a baseline high level (>80%) to an even higher level (>95%) could lead to ...
  55. [55]
    Five moments for hand hygiene - World Health Organization (WHO)
    Mar 4, 2021 · Overview. It takes just 5 moments to change the world. Clean your hands, stop the spread of drug-resistant germs!
  56. [56]
    The World Health Organization '5 moments of hand hygiene' - PubMed
    The WHO '5 moments of hand hygiene' prompts healthcare workers to clean hands at five stages of patient care, but a review found no strong scientific support.<|separator|>
  57. [57]
    Replace Hand Washing with Use of a Waterless Alcohol Hand Rub?
    Alcoholic compounds used as hand rub kill 3.2–5.8 log10 cfu, compared with the 1.8–2.8 log10 cfu in 30 seconds removed with medicated soap [3, 31].<|control11|><|separator|>
  58. [58]
    Clinical Safety: Hand Hygiene for Healthcare Workers - CDC
    Feb 27, 2024 · Unless hands are visibly soiled, alcohol-based hand sanitizer (ABHS) is preferred over soap and water for cleaning hands in most clinical ...
  59. [59]
    Hand Sanitizer Facts | Clean Hands - CDC
    Apr 17, 2024 · Soap and water are more effective than hand sanitizers at removing certain kinds of germs, like Cryptosporidium, norovirus, and Clostridium ...
  60. [60]
    About Hand Hygiene for Patients in Healthcare Settings - CDC
    Feb 27, 2024 · Wet your hands with warm water. Use liquid soap if possible. Apply a nickel- or quarter-sized amount of soap to your hands. Rub your hands ...
  61. [61]
    About Handwashing | Clean Hands - CDC
    Feb 16, 2024 · Wet your hands with clean, running water (warm or cold), turn off the tap, and apply soap. · Lather your hands by rubbing them together with the ...Hand Hygiene in Healthcare · Hand Hygiene FAQs · About Hand Hygiene as a...
  62. [62]
    Hand Hygiene - StatPearls - NCBI Bookshelf - NIH
    According to the CDC, established guidelines recommend that agents used for surgical hand scrubs should reduce microorganisms on intact skin in a substantial ...
  63. [63]
    Guideline for Hand Hygiene in Healthcare Settings (2002) - CDC
    Mar 18, 2024 · This guideline provides recommendations for hand hygiene in healthcare settings. Format: PDF. Page count: 56. Language: English (US). Size: 495 ...
  64. [64]
    Cleaning | Infection Control - CDC
    Nov 28, 2023 · Thorough cleaning is required before high-level disinfection and sterilization because inorganic and organic materials that remain on the ...
  65. [65]
    [PDF] Best Practices for Cleaning, Disinfection and Sterilization of Medical ...
    May 21, 2013 · Infection Control Guidelines: Hand Washing, Cleaning, Disinfection and Sterilization in. Health Care [currently under revision]. Can Commun ...
  66. [66]
    Disinfection and Sterilization in Health Care Facilities
    Cleaning should always precede high-level disinfection and sterilization. Current disinfection and sterilization guidelines must be strictly followed. Keywords: ...
  67. [67]
    Disinfection | Infection Control - CDC
    Nov 28, 2023 · Disinfection recommendations for Guideline for Disinfection and Sterilization in Healthcare Facilities.
  68. [68]
    Chemical Disinfectants | Infection Control - CDC
    Nov 28, 2023 · The quaternaries sold as hospital disinfectants are generally fungicidal, bactericidal, and virucidal against lipophilic (enveloped) viruses.Missing: physical | Show results with:physical
  69. [69]
    Chemical disinfection in healthcare settings: critical aspects for the ...
    These guidelines include a list of hospital-grade disinfectant substances for use in all healthcare settings such as alcohols (60–90% ethyl or isopropyl alcohol) ...
  70. [70]
    [PDF] Care, cleaning, disinfection and sterilization of respiratory devices
    Cleaning, disinfection and sterilization are the backbone of infection prevention and control in hospitals and or other health care facilities.
  71. [71]
    Sterilization | Infection Control - CDC
    Nov 28, 2023 · This section reviews sterilization technologies used in healthcare and makes recommendations for their optimum performance in the processing of medical devices.<|separator|>
  72. [72]
    [PDF] STERILIZATION METHODS, TECHNIQUES AND CAPABILITIES
    Steam Autoclave – Moist heat autoclaving is the fastest and most reliable form of sterilization in the medical equipment industry. Designed to use high pressure ...
  73. [73]
    Other Sterilization Methods | Infection Control - CDC
    Dec 11, 2023 · Sterilization by ionizing radiation, primarily by cobalt 60 gamma rays or electron accelerators, is a low-temperature sterilization method that has been used ...
  74. [74]
    Medical Device Sterilization: Methods Explained, Compared ...
    Mar 29, 2022 · Sterilization techniques for medical devices include physical, chemical, and radiation procedures. Each sterilization process has unique ...
  75. [75]
    Sterilizing Practices | Infection Control - CDC
    Nov 28, 2023 · Healthcare personnel should perform most cleaning, disinfecting, and sterilizing of patient-care supplies in a central processing department in order to more ...
  76. [76]
    Personal Protective Equipment - StatPearls - NCBI Bookshelf - NIH
    Feb 22, 2023 · Commonly worn PPE includes a gown, gloves, masks, respirators, and face shields or goggles. Understanding the limitations and proper wearing of PPE is ...
  77. [77]
    Precautions, Bloodborne, Contact, and Droplet - StatPearls - NCBI
    Use of appropriate protective equipment (i.e., gloves) before patient contact ... personal protective equipment (PPE) required for each kind of precaution.Definition/Introduction · Issues of Concern · Nursing, Allied Health, and...
  78. [78]
    Personal Protective Equipment for Infection Control - FDA
    Feb 10, 2020 · This includes surgical masks, N95 respirators, medical gloves, and gowns. The consensus standards and the FDA's requirements vary depending on ...
  79. [79]
    [PDF] Sequence for Putting on Personal Protective Equipment (PPE) - CDC
    The procedure for putting on and removing PPE should be tailored to the specific type of PPE. 1. GOWN. • Fully cover torso from neck to knees, arms to end of ...
  80. [80]
    Donning and Doffing PPE: Proper Wearing, Removal, and Disposal
    Donning is putting on PPE to minimize exposure, doffing is removing it to avoid self-contamination. Remove PPE before entering non-clinical areas. Wash hands ...
  81. [81]
    Improving the Use of Personal Protective Equipment
    Sep 13, 2019 · In summary, PPE plays an important role in preventing pathogen transmission in healthcare settings, but its optimal design and use need to be ...
  82. [82]
    Rapid review and meta-analysis of the effectiveness of personal ...
    Overall, the review results show that wearing face masks can significantly protect HCWs from infection. We found no effects for wearing gloves and gowns.
  83. [83]
    Personal Protective Equipment and Infection Control: Evaluating the ...
    A systematic search of peer-reviewed studies from 2016 onward revealed that proper PPE use significantly reduces infection risks, with reductions of up to 85% ...<|separator|>
  84. [84]
    Personal protective equipment implementation in healthcare
    Protective personal equipment implementation is a complex cycle of elements all of which are required to achieve optimal use.
  85. [85]
    Antimicrobial surfaces to prevent healthcare-associated infections
    Copper surfaces used in clinical settings result in modest reductions in microbial contamination. One study of copper surfaces and one of copper textiles ...
  86. [86]
    Antimicrobial coatings for environmental surfaces in hospitals
    Antimicrobial coatings (AMC) may permanently and autonomously reduce the contamination of such environmental surfaces complementing standard hygiene procedures.
  87. [87]
    Evidence that contaminated surfaces contribute to the transmission ...
    This review presents evidence that contaminated surfaces contribute to transmission and discusses the various strategies currently available to address ...
  88. [88]
    The Use of Copper as an Antimicrobial Agent in Health Care ... - NIH
    Many in vitro studies have demonstrated the antimicrobial effect of copper on a wide spectrum of Gram-positive bacteria (i.e., Enterococcus spp.
  89. [89]
    Effectiveness of Copper-Impregnated Solid Surfaces on Lowering ...
    Jun 19, 2020 · Copper-impregnated solid surfaces may reduce the level of microbial contamination on high-touch surfaces in patient rooms in the acute care ...
  90. [90]
    Effectiveness of copper as a preventive tool in health care facilities ...
    Feb 25, 2023 · Two-thirds of studies show copper reduces microbial burden. Copper may be effective in healthcare, but further studies are needed to confirm ...
  91. [91]
    Does copper treatment of commonly touched surfaces reduce ...
    Sep 8, 2020 · This review found low-quality evidence of potential clinical importance that copper-treated hard surfaces and/or bed linens and clothes reduced HAIs by 27%.
  92. [92]
    Impact of antimicrobial copper surfaces on microbial load and ...
    The results demonstrated a 79.3% and 34.1% overall reduction in microbial load on antimicrobial copper surfaces compared to existing surfaces using the ATP ...<|separator|>
  93. [93]
    Antimicrobial Treatment of Polymeric Medical Devices by Silver ...
    The use of silver to reduce the risk of nosocomial infection has gained importance in recent days [43,44]. The antimicrobial effect of silver and silver ...
  94. [94]
    Long-term antimicrobial effectiveness of a silver-impregnated foil on ...
    Aug 16, 2021 · A foil containing an integrated silver-based agent applied to high-touch surfaces effectively results in lower recovery of important pathogens ...
  95. [95]
    Nanosilver/DCOIT-containing surface coating effectively and ...
    Mar 21, 2023 · A newly developed antimicrobial coating containing nanosilver in long-term reduction of bacterial burden in hospital surfaces to close the gap between routine ...
  96. [96]
    Full article: Evaluating the antibacterial efficacy of a silver ...
    Antimicrobial nanocoatings may be a means of preventing nosocomial infections, which account for significant morbidity and mortality. The role of hospital ...
  97. [97]
    Antimicrobial surfaces: time to rethink surface disinfection?
    Nov 19, 2024 · No clinical outcomes. A major limitation of this study is that patient outcomes were not measured in terms of microbial transmission or HCAI.
  98. [98]
    [PDF] Antimicrobials in hospital furnishings: - Health Care Without Harm
    Aug 11, 2020 · No current high-quality evidence indicates that adding antimicrobial agents to the surfaces of products adds significant value beyond the array ...
  99. [99]
    Recent advances in copper and copper-derived materials for ...
    Copper is also utilized in wound dressings to prevent infections and encourage wound healing [9] and as an antibacterial coating for implant surfaces [10,11] ...
  100. [100]
    Editorial: Reducing healthcare-associated infections through ...
    Jul 9, 2024 · The study contributes valuable insights for the safe and effective use of antimicrobial textiles to enhance infection control in healthcare ...
  101. [101]
    Prevention of Device-Related Healthcare-Associated Infections - PMC
    Jan 14, 2016 · The use of prevention bundles has been shown to reduce HAI rates. A bundle is best defined as a grouping of evidence-based practices that ...
  102. [102]
    HAIs: Reports and Data - CDC
    One in 31‎​​ On any given day, about one in 31 hospital patients has at least one healthcare-associated infection.
  103. [103]
    Current HAI Progress Report - CDC
    Nov 25, 2024 · The 2023 annual National and State Healthcare-Associated Infections (HAI) Progress Report provides a summary of select HAIs across four healthcare settings.
  104. [104]
    Care bundle approach to reduce device-associated infections in a ...
    The care bundle approach is a set of evidence-based practices that when performed collectively and reliably have been shown to improve the patient outcome.
  105. [105]
    Strategies for Prevention of Catheter-Related Infections in Adult and ...
    Feb 28, 2024 · Maximum sterile barrier (MSB) precautions are defined as wearing a sterile gown, sterile gloves, and cap and using a full body drape (similar to ...Missing: VAP | Show results with:VAP
  106. [106]
    Strategies to prevent central line-associated bloodstream infections ...
    This document updates the Strategies to Prevent Central Line-Associated Bloodstream Infections in Acute-Care Hospitals published in 2014.
  107. [107]
    [PDF] Checklist for Prevention of Central Line Associated Blood Stream ...
    Perform hand hygiene before insertion. Adhere to aseptic technique. Use maximal sterile barrier precautions (i.e., mask, cap, gown, sterile gloves, and sterile ...Missing: CAUTI | Show results with:CAUTI
  108. [108]
    Preventing Catheter-associated Urinary Tract Infections (CAUTIs) | UTI
    Jun 27, 2025 · Only use urinary catheters when needed. · Place catheters using proper germ-free techniques with sterile equipment. · Maintain the catheter's ...Missing: CLABSI VAP
  109. [109]
    Catheter-Associated Urinary Tract Infections (CAUTI) Prevention ...
    Apr 12, 2024 · This guideline provides recommendations for prevention of catheter-associated urinary tract infections.Updates · Summary of Recommendations · V. Background · AbbreviationsMissing: device- CLABSI VAP<|separator|>
  110. [110]
    Compendium of Strategies to Prevent Healthcare-Associated ...
    Concise recommendations on core infection prevention practices to prevent six HAIs that have major impacts on quality and safety of patient care.
  111. [111]
    Guidelines for the prevention of bloodstream infections and other ...
    May 12, 2024 · These guidelines (Part 1) provide guidance on best practices for the prevention of BSIs and other infections associated with peripherally-inserted IV catheters.
  112. [112]
    [PDF] Bloodstream Infection Event (Central Line-Associated ... - CDC
    A BSI with a DOE on the day of or the day after device removal or patient discharge is considered a device-associated infection (CLABSI). The patient ...
  113. [113]
    C. Air | Infection Control - CDC
    Dec 21, 2023 · Health-care facilities without specific ventilation standards should follow the AIA guideline specific to the year in which the building was ...
  114. [114]
    Increasing ventilation reduces SARS-CoV-2 airborne transmission ...
    From the regression analysis we obtained a relative risk reduction in the range 12%15% for each additional unit of ventilation rate per person. The results also ...
  115. [115]
    Natural ventilation for reducing airborne infection in hospitals - PMC
    High ventilation rate is shown to be effective for reducing cross-infection risk of airborne diseases in hospitals and isolation rooms.
  116. [116]
    Isolation Precautions Guideline | Infection Control - CDC
    Nov 27, 2023 · Isolation Precautions Guideline. What to know. This guideline provides recommendations for isolation precautions in healthcare settings.Appendix A: Type and... · Appendix A · Appendix A: Table 1. History of... · Updates
  117. [117]
    Appendix A: Type and Duration of Precautions Recommended for ...
    Feb 7, 2025 · Transmission through non-intact skin contact with draining lesions possible, therefore use Contact Precautions if large amount of uncontained ...
  118. [118]
    Infection Control and Isolation Procedures - The EBMT Handbook
    Apr 11, 2024 · Infection control is defined as a set of measures aimed at preventing or stopping the spread of infections in healthcare settings.Introduction · Transmission-Based Precautions · Management of the Threat of...
  119. [119]
    Ventilation control for airborne transmission of human exhaled bio ...
    Higher ventilation rate is proved to reduce the risk of airborne infection, however, there is still a lack of scientific evidence of minimum ventilation rate.
  120. [120]
    Room ventilation and the risk of airborne infection transmission in 3 ...
    Jun 10, 2011 · Room ventilation is a key determinant of airborne disease transmission. Despite this, ventilation guidelines in hospitals are not founded on ...
  121. [121]
    The future of healthcare‐associated infection surveillance
    Healthcare‐associated infections (HAIs) are common adverse events, and surveillance is considered a core component of effective HAI reduction programmes.
  122. [122]
    Designing Surveillance of Healthcare-Associated Infections in the ...
    Sep 18, 2017 · Surveillance and feedback of infection rates to clinicians and other stakeholders is a cornerstone of healthcare-associated infection (HAI) prevention programs.<|control11|><|separator|>
  123. [123]
    Infectious Disease Surveillance - PMC - PubMed Central
    Active surveillance aims to detect every case, and passive surveillance likely misses cases due to the reporting structure. Although active surveillance is more ...
  124. [124]
    Monitoring Infections: Active vs. Passive Surveillance
    Apr 10, 2012 · Active surveillance involves prospective steps to identify patients who have or who may develop HAIs, using standardized definitions of infection.Missing: methods | Show results with:methods<|separator|>
  125. [125]
    Hunting Health Care-Associated Infections from the Clinical ...
    Passive surveillance, as noted earlier, requires personnel untrained in epidemiology or infection control to detect a pattern of unusual infections as part of ...
  126. [126]
    Development of a knowledge-based healthcare-associated ...
    Oct 10, 2023 · In particular, active surveillance of HAIs has been shown to reduce the incidence of bloodstream infections by 44%, urinary tract infections by ...
  127. [127]
    NHSN - CDC
    CDC's National Healthcare Safety Network is the nation's most widely used healthcare-associated infection tracking system.Acute Care Hospitals/Facilities · NHSN Reports · Long-term Care Facilities · About
  128. [128]
    [PDF] National Healthcare Safety Network (NHSN) Overview - CDC
    CDC's NHSN is a secure, web-based surveillance application that is the nation's most widely used healthcare-associated infection (HAI) tracking system. The ...
  129. [129]
    Electronically assisted surveillance systems of healthcare ...
    Surveillance of healthcare-associated infections (HAI) entails the systematic collection of data on the presence of HAI, analysis and transformation of the data ...
  130. [130]
    Healthcare-associated infections and conditions in the era of digital ...
    Sep 25, 2023 · Traditionally, HAI surveillance has been performed by infection preventionists who conduct manual medical record reviews of all patients at risk ...
  131. [131]
    Effect of a real-time automatic nosocomial infection surveillance ...
    Nov 16, 2022 · The adoption of a RT-NISS to adequately and accurately collect HAI cases is useful to prevent and control HAIs.
  132. [132]
    [PDF] APIC Position Paper: The Importance of Surveillance Technologies ...
    May 29, 2009 · Computer-based surveillance can facilitate good stewardship by facilitating more efficient targeting of antimicrobial interventions, tracking of.
  133. [133]
    About Outbreak Investigations in Healthcare Settings | HAIs - CDC
    Apr 15, 2024 · Providing tools and resources for health departments and healthcare facilities investigating healthcare-associated infection (HAI) outbreaks, ...
  134. [134]
    Conducting a Field Investigation | Field Epi Manual - CDC
    Jan 6, 2025 · Step 1. Prepare for Field Work · Step 2. Confirm the Diagnosis · Step 3. Determine the Existence of an Outbreak · Step 4. Identify and Count Cases.
  135. [135]
    Stages of an outbreak investigation
    Conduct initial investigation to confirm the existence of an outbreak and verify the diagnosis · Implement immediate and generic control measures, if possible.
  136. [136]
    Legal Authorities for Isolation and Quarantine | Port Health - CDC
    May 15, 2024 · Isolation and quarantine help protect the public by preventing exposure to people who have or may have a contagious disease. Isolation separates ...
  137. [137]
    Effectiveness of isolation, testing, contact tracing, and physical ...
    We estimated that combined isolation and tracing strategies would reduce transmission more than mass testing or self-isolation alone.
  138. [138]
    Infection Prevention and Control Recommendations for Patients in ...
    Oct 31, 2024 · This guidance outlines the key areas for infection prevention and control for VHFs in US hospitals and healthcare settings.<|separator|>
  139. [139]
    Implementing Quarantine to Reduce or Stop the Spread of a ... - NCBI
    The evidence suggests that quarantine can be effective at reducing overall disease transmission in the community in certain circumstances (high COE based on ...
  140. [140]
    Quantifying the impact of quarantine duration on COVID-19 ... - eLife
    Feb 5, 2021 · The analysis predicted that shortening quarantines from ten to seven days would result in almost no increased risk of transmission.
  141. [141]
    Evidence and Effectiveness in Decisionmaking for Quarantine | AJPH
    Oct 14, 2011 · (The terms quarantine and isolation ... Here they mean that there is no empirical evidence supporting the effectiveness of large-scale quarantine.
  142. [142]
    a multi-stage SEIQR modeling approach to COVID-19 transmission ...
    Jul 1, 2025 · Simulations reveal that timely and stringent quarantine interventions can reduce peak caseloads by up to 30%, delaying outbreak surges and ...<|separator|>
  143. [143]
    Universal Hepatitis B Vaccination in Adults Aged 19–59 Years - CDC
    Apr 1, 2022 · Vaccination with hepatitis B (HepB) vaccines shows well-established safety and efficacy. However, because of risk factor−based approaches of ...
  144. [144]
    Benefits of Hepatitis B Vaccines in Healthcare Workers
    Sep 10, 2024 · Long-term protection against hepatitis B infection is conferred by the vaccine and the protective immune response is indicated by anti-hepatitis ...
  145. [145]
    Influenza vaccination in healthcare workers - PubMed Central - NIH
    Authors found a vaccine efficacy of 88% for influenza A and 89% for influenza B. Moreover, the vaccine contributed to decrease cumulative days of febrile ...
  146. [146]
    Effectiveness of Influenza Vaccine in Health Care Professionals
    Conclusions Influenza vaccine is effective in preventing infection by influenza A and B in health care professionals and may reduce reported days of work ...<|separator|>
  147. [147]
    Are healthcare workers immunized after receiving hepatitis B ... - NIH
    Conclusion: This study showed that the vaccine protocol is effective in immunizing health professionals against hepatitis B.
  148. [148]
    [PDF] Healthcare Personnel Vaccination Recommendations - Immunize.org
    A combination MenABCWY vaccine is an option when both products are indicated at the same visit. The minimum interval between MenABCWY doses is 6 months.
  149. [149]
    Mandatory Flu Vaccine for Healthcare Workers: Not Worthwhile
    Apr 17, 2019 · Thus, there is no evidence to date that vaccinating healthcare workers will indirectly reduce influenza infection in patients in long-term care ...Abstract · PRESENTEEISM · INFLUENZA VACCINE · ANALYSIS OF INFLUENZA...
  150. [150]
    Interim Estimates of 2024–2025 COVID-19 Vaccine Effectiveness ...
    Feb 27, 2025 · Vaccine effectiveness (VE) of 2024–2025 COVID-19 vaccine was 33% against COVID-19–associated emergency department (ED) or urgent care (UC) visits among adults ...Missing: workers | Show results with:workers
  151. [151]
    Are COVID-19 vaccination mandates for healthcare workers ...
    Healthcare vaccine mandates were broadly effective in increasing vaccination uptake. The effect of the mandates on healthcare worker (HCW) COVID-19 infection ...
  152. [152]
    Vaccination policies for healthcare personnel: Current challenges ...
    Vaccinations of HCP are justified to confer them immunity but also to protect susceptible patients and healthcare services from outbreaks, HCP absenteeism and ...
  153. [153]
    Impacts of State COVID-19 Vaccine Mandates for Health Care ...
    Feb 12, 2025 · Results further ruled out a mandate-associated decrease in employment larger than 2.1% of premandate employment levels for the 6 health care ...
  154. [154]
    Serologic Hepatitis B Immunity in Vaccinated Health Care Workers
    Background Hepatitis B vaccination is recommended for health care workers but has a nonresponse rate of 5% to 32% and an unknown duration of immunity.
  155. [155]
    Table 4: Summary of WHO Position Papers – Immunization of Health ...
    Dec 6, 2024 · Table 4 summarizes WHO's recommendations for the vaccination of health care workers.
  156. [156]
    Healthcare-associated infections: potential for prevention through ...
    Historic and current vaccines have already contributed to reductions in healthcare-associated infections, and future vaccines have the potential to reduce these ...
  157. [157]
    Counting the impact of vaccines - World Health Organization (WHO)
    Apr 22, 2021 · 1. Immunization saves lives and protects peoples' health. Immunization keeps people healthy and has reduced the number of deaths from infectious diseases ...
  158. [158]
    Vaccines and immunization - World Health Organization (WHO)
    Immunization currently prevents 3.5 million to 5 million deaths every year from diseases like diphtheria, tetanus, pertussis (whooping cough), influenza and ...
  159. [159]
    “Herd Immunity”: A Rough Guide | Clinical Infectious Diseases
    A common implication of the term is that the risk of infection among susceptible individuals in a population is reduced by the presence and proximity of immune ...
  160. [160]
    Universal Influenza Vaccination Among Healthcare Personnel
    Apr 17, 2019 · In these studies, vaccination of 100% of HCP in the acute care model resulted in a 43% reduction in the risk of influenza among hospitalized ...<|separator|>
  161. [161]
    Health and Economic Benefits of Routine Childhood Immunizations ...
    Aug 8, 2024 · Immunizations have contributed to substantial declines in morbidity and mortality associated with vaccine-preventable diseases worldwide. Broad ...
  162. [162]
    Patient influenza vaccination reduces the risk of hospital-acquired ...
    Jul 5, 2023 · A better control of HAI can be achieved by vaccinating hospitalized patients. Introduction. Influenza is a viral respiratory acute infection ...
  163. [163]
    Vaccines of Importance in the Hospital Setting - ScienceDirect.com
    Immunizing patients protects them against preventable illnesses that may be acquired in the hospital or the community following discharge. Previous article in ...
  164. [164]
    The importance of immunization as a public health instrument - PMC
    Together with clean water and improved access to health care, immunizations have contributed in a definitive and relevant way to the increase in life expectancy ...
  165. [165]
    Vaccines for Healthcare-associated Infections: Promise and Challenge
    Vaccines directed toward these pathogens could help prevent a large number of HAIs and associated antibiotic use if administered to targeted populations.Abstract · CLOSTRIDIUM DIFFICILE · STAPHYLOCOCCUS AUREUS · CANDIDA
  166. [166]
    Vaccines for healthcare associated infections ... - ScienceDirect.com
    Until preventive vaccines are available, infection control measures continue to be crucial in the prevention of HAIs and should be strengthen.
  167. [167]
    Benefits of integrated screening and vaccination for infection control
    The findings in this study suggest that including the vaccinated population in the screening pool can potentially decrease the number of infections, although ...
  168. [168]
    Impact of Vaccines; Health, Economic and Social Perspectives
    Reduction in Infectious Diseases Morbidity and Mortality. The most significant impact of vaccines has been to prevent morbidity and mortality from serious ...
  169. [169]
    Core competencies for infection prevention and control professionals
    Sep 17, 2020 · The purpose of this document is to define who is the infection prevention and control (IPC) professional and identify what core competencies are needed to be ...
  170. [170]
    CDC/STRIVE Infection Control Training
    Apr 3, 2024 · Courses address both the technical and foundational elements of healthcare-associated infection (HAI) prevention. Courses can be taken in any order.
  171. [171]
    Infection preventionist (IP) competency model - APIC
    The APIC Competency Model for the Infection Preventionist includes the CBIC core competencies and the APIC Professional and Practice Standards (PPS).
  172. [172]
    [PDF] Core Competencies for Infection Prevention and Control ...
    There are five foundational core competencies: education, microbiology, routine practices and additional precautions, surveillance and epidemiology, and ...
  173. [173]
    5. Occupational Infection Prevention and Control: Education ... - CDC
    Apr 12, 2024 · Occupational IPC education and training programs are intended to increase HCP knowledge, competency, and practical skills about infectious diseases and their ...
  174. [174]
    Evaluation of the Effectiveness and Perceived Benefits of ...
    In this study, we assessed the IPC knowledge of undergraduate clinical-year medical students before and after interventional IPC modular training.
  175. [175]
    Measuring the effectiveness of an integrated intervention package to ...
    Our study aimed to assess the effect of an integrated intervention package in improving the IPC level of the health facilities in Bangladesh.
  176. [176]
    Effectiveness of infection prevention and control interventions in ...
    Our review suggests that IPC interventions could potentially reduce HAIs and improve compliance with hand hygiene in health care facilities in Africa.
  177. [177]
    Assessing infection control training in ICUs using the Kirkpatrick model
    Jun 9, 2025 · This study aimed to evaluate the impact of a structured infection prevention and control (IPC) training program on the knowledge, behavior, and ...
  178. [178]
    [PDF] Impact of Infection Control Training Program in Improving the Quality ...
    Oct 19, 2020 · Well-designed evidence- based IPC training programs may significantly reduce the incidence of HAIs in the healthcare facilities as much as 65% ...
  179. [179]
    Determinants of hand hygiene compliance among healthcare ...
    Aug 28, 2024 · The compliance with hand hygiene protocols was much lower in ICUs (30–40%) compared to regular wards (50–60%) [28].
  180. [180]
    First-ever WHO research agenda on hand hygiene in health care to ...
    May 12, 2023 · Average hand hygiene compliance without specific improvement interventions remains at around 40%, while in critical care, such as intensive care ...
  181. [181]
    Barriers and solutions regarding to infection prevention and control ...
    CONCLUSIONS. According to HCWs, increased workload, structural issues, and inefficient training modules were identified as the main IPC barriers. Qualitative ...
  182. [182]
    Barriers and Facilitators of Health Care Workers' Compliance - LWW
    Key barriers include lack of knowledge and training, time constraints, workload, inadequate resources, and cultural and behavioral factors.
  183. [183]
    Assessment of Perceived Compliance and Barriers to Personal ...
    The main perceived barriers to the use of PPEs were unavailability of full PPEs (35%), interference with their ability to provide patient care (29%), not enough ...
  184. [184]
    Factors affecting healthcare workers' compliance with ... - BMJ Open
    Staff identified many barriers to compliance related to personal protective equipment, including availability, perceived difficulty and effectiveness, ...
  185. [185]
    Barriers to using personal protective equipment by... : Medicine - LWW
    Nov 25, 2020 · Difficulties mentioned by the participants were classified into 6 themes: inappropriate PPE size, design of PPE and complexity of use, doubts ...
  186. [186]
    Barriers and Facilitators to the Use of Personal Protective Equipment ...
    Dec 3, 2022 · Other barriers to PPE use include difficulty providing care, and anxiety about frightening patients. PPE being readily available facilitated its ...
  187. [187]
    a qualitative study exploring non-compliance through appraisals of ...
    This qualitative study sought to identify behaviours of HCWs that facilitated non-compliance with IPC practices, focusing on how appraisals of IPC duties and ...
  188. [188]
    Determinants of Nurses' Compliance with Infection Prevention and ...
    Apr 30, 2025 · Nurses' adherence to IPC protocols is influenced by personal, organizational, and environmental factors. Individual attitudes toward IPC ...
  189. [189]
    Factors influencing healthcare workers' perceived compliance with ...
    Jan 30, 2025 · Two key factors influencing compliance with IPC standards are healthcare workers' knowledge and attitudes. Knowledge provides the foundation ...
  190. [190]
    Barriers and facilitators to healthcare workers' adherence with ...
    To identify barriers and facilitators to healthcare workers' adherence to IPC guidelines for respiratory infectious diseases.
  191. [191]
    Barriers and facilitators of compliance with infection prevention and ...
    Among the barriers to IPC compliance were inadequate knowledge of IPC among HCWs, high workload, lack of resources to procure PPE, vaccination status against ...<|separator|>
  192. [192]
    [PDF] Factors Affecting Compliance to Infection Prevention Control among ...
    May 26, 2025 · This study aims to determine factors affecting compliance with infection prevention and control (IPC) standards among frontline health workers.
  193. [193]
    Health Care–Acquired Infections in Low- and Middle-Income ...
    Aug 4, 2021 · Many MDRO originate in LMIC where the ability to control the spread can be limited due to a lack of resources.
  194. [194]
    WHO launches first ever global report on infection prevention and ...
    May 6, 2022 · “The COVID-19 pandemic has exposed many challenges and gaps in IPC in all regions and countries, including those which had the most advanced IPC ...
  195. [195]
    Challenges and opportunities for infection prevention and control in ...
    Dec 20, 2021 · Participants described that inadequate and poorly maintained buildings were a barrier to effective IPC. Damaged surfaces, including walls and ...
  196. [196]
    The burden of health care-associated infection - NCBI - NIH
    Limited data are available from LMICs, but the prevalence of HAI is estimated to be between 5.7% and 19.1%. The increased burden of HAI in LMICs affects ...
  197. [197]
    New report highlights need for sustained investment in infection ...
    Nov 29, 2024 · The report also highlights that patients in low- and middle-income countries (LMICs) have up to 20 times higher risk of acquiring infections ...
  198. [198]
    WHO report highlights burden, impact of healthcare-associated ...
    Dec 2, 2024 · Similarly, the incidence of HAIs in intensive care units is 30% overall but 2 to 20 times higher in LMICs than HICs. Compounding the problem is ...
  199. [199]
    Real-world implementation challenges in low-resource settings
    Aug 18, 2021 · Fixed budgets, overwhelmed resources, and weak engagement are particular challenges in LMIC settings.
  200. [200]
    Global incidence in hospital-associated infections resistant to ...
    Jun 13, 2023 · Low- and middle-income settings (LMICs) that have poor antimicrobial stewardship and limited microbiology diagnostic capacities are grossly ...
  201. [201]
    The challenges of implementing infection prevention and ...
    Apr 16, 2024 · Barriers to implementing effective antimicrobial stewardship and infection prevention programs include the lack of a structural framework, consensus guidelines ...
  202. [202]
    Rationale and guidance for strengthening infection prevention and ...
    Oct 7, 2022 · Healthcare facilities in resource-constrained settings require context-specific evidence to identify and respond to gaps in infection control ...
  203. [203]
    View of Nursing Interventions for Preventing Hospital-Acquired ...
    The meta-analysis revealed that hand hygiene adherence led to a 35% reduction in HAIs, with an odds ratio (OR) of 0.65 (95% CI: 0.54–0.79). Structured ...
  204. [204]
    Key facts and figures - World Health Organization (WHO)
    On average, around 1 in 10 patients is affected by HAIs; however, the frequency can be much higher in low-/middle-income countries and in high-risk patients ...<|control11|><|separator|>
  205. [205]
    Impact of Hand Hygiene Compliance on Hospital Acquired Infection ...
    HH could be a simple and cost-effective method in prevention of HAIs and also reduce the patient hospital stay, financial burdens and mainly the resistance ...<|separator|>
  206. [206]
    Compared hand hygiene compliance among healthcare providers ...
    A 3 year observational study showed a 10% improvement in HH associated with a 6% reduction in overall HAIs. During the COVID-19 pandemic, poor HH has been shown ...
  207. [207]
    Reduction of Healthcare-Associated Infections by Exceeding High ...
    We noted a significant increase in overall hand hygiene compliance rate (p<0.001) and a significantly decreased overall HAI rate (p = 0.0066), supported by 197 ...
  208. [208]
    Long-term sustainability of zero central-line associated bloodstream ...
    Reported intervention studies have shown success in reduction of CLABSI rates but few have reported long-term improvements. Recently, interventions for control ...
  209. [209]
    Multimodal interventions for bundle implementation to decrease ...
    3, 12 In this study, we aimed to exam whether multimodal interventions, focusing on CL bundle improvement, can reduce the incidence of CLABSI and catheter- ...
  210. [210]
    Nurses' Knowledge and Behavior in Hospitals Regarding the ...
    May 30, 2025 · Effectiveness of the CLABSI Bundle: Five studies confirmed the effectiveness of the CLABSI bundle in significantly reducing infection rates ...
  211. [211]
    Understanding the Economic Impact of Health Care-Associated ...
    A 1995 review of the published research on the cost of HAIs to hospitals found that the economic evidence on cost of HAI infection control and prevention ...
  212. [212]
    Economic analysis of healthcare-associated infection prevention ...
    For every dollar invested in the hand hygiene campaign, we would save between $CAD 9.3 and $CAD 18.1 based on the discount rates of 3% and 8%, respectively. For ...
  213. [213]
    Hand hygiene - Infection prevention and control
    Hand hygiene improvement programmes can prevent up to 50% avoidable infections acquired during health care delivery and generate economic savings.Five moments for hand hygiene · Hand hygiene for all initiative · Training tools
  214. [214]
    Cost-effectiveness analysis of alcohol handrub for the prevention of ...
    Mar 4, 2022 · This study evaluates the cost-effectiveness of a multimodal hand hygiene involving alcohol-based hand rub (ABH) for the prevention of neonatal BSI<|separator|>
  215. [215]
    Cost-effectiveness of an Environmental Cleaning Bundle for ...
    Jul 30, 2019 · This study evaluates the cost-effectiveness of the environmental cleaning bundle for reducing the incidence of HAIs.
  216. [216]
    Cost-effectiveness of Infection Control Strategies to Reduce Hospital ...
    Aug 13, 2020 · This economic evaluation study compares the cost-effectiveness of 9 Clostridioides difficile single intervention strategies and 8 ...
  217. [217]
    A systematic review of economic evaluation of healthcare ...
    Nov 29, 2024 · Studies were restricted to four CBPs in IPC programs: (1) hand hygiene; (2) hygiene and sanitation of surfaces and equipment; (3) screening ...
  218. [218]
    Economic evaluations and their use in infection prevention and control
    Feb 27, 2018 · The authors determined that by continuing to use an IPC program to prevent HAI in ICUs, it would cost $14,250 per life year gained and $23,277 ...Missing: critiques overestimation
  219. [219]
  220. [220]
    Umbrella review of economic evaluations of interventions for the ...
    An umbrella review was conducted to identify evidence on the cost-effectiveness of antimicrobial stewardship, infection prevention and control, and microbiology ...
  221. [221]
    Infection prevention and control research priorities: what do we need ...
    Aug 24, 2020 · This comparison revealed three potential gaps: (i) clinical trials efficiency, (ii) AMR in the food chain and (iii) IPC. Yet, the first two gaps ...<|separator|>
  222. [222]
    228. Infection Control Cluster Randomized Control Trials and ...
    Dec 15, 2022 · Organizational readiness can delay or impede important infection control CRCTs. This study exemplifies the complexity of healthcare ...
  223. [223]
    Where is the strength of evidence? A review of infection prevention ...
    This study aimed to describe the strength of recommendations of infection prevention and control guidelines published in the last 10 years.
  224. [224]
    The effectiveness of quality management interventions in reducing ...
    This systematic literature review evaluates the effectiveness of Quality Management Tools (QMTs) in reducing Hospital-Associated Infections (HAIs) among adult ...
  225. [225]
    Effectiveness of Infection Control Teams in Reducing Healthcare ...
    Dec 19, 2022 · Nine RCTs were included; all were rated as being low quality. Overall, ICT, with or without an ICLN system, did not reduce the incidence rate of ...<|separator|>
  226. [226]
    Research Gaps in Patient and Healthcare Personnel Safety - CDC
    Apr 19, 2024 · This report is intended to help investigators, funders, state and local health departments, and patient advocates understand key priority research questions ...
  227. [227]
    [PDF] Research Gaps in Patient and Healthcare Personnel Safety - CDC
    The prevention of healthcare-associated infections (HAIs) and antimicrobial-resistant (AR) infections is a mixed story of progress and setbacks with a long path ...
  228. [228]
    striving for evidence based practice in infection prevention and control
    May 23, 2024 · This article provides an overview of the guideline development process and summarises the current recommendations from WHO for IPC measures.Who Guideline Development... · Ipc Measures For Patients... · Community SettingsMissing: empirical | Show results with:empirical
  229. [229]
    Unintended consequences of infection prevention and control ...
    Enhanced infection control measures resulted in the unintended positive consequences of containing health care-associated respiratory viral infections, with ...
  230. [230]
    Dramatically improved hand hygiene performance rates at time of ...
    Aug 7, 2025 · The study also found a positive relationship between local COVID-19 epidemic and hand hygiene practices during patient care and on room exit ( ...
  231. [231]
    Effect of the coronavirus disease 2019 pandemic on beliefs... - LWW
    Mar 21, 2025 · All nurses (100%) agreed that the COVID-19 pandemic had affected their hand hygiene practices. The rate of increased frequency of hand washing ...
  232. [232]
    The impact of enhanced cleaning on bacterial contamination of the ...
    Nov 19, 2024 · There is evidence that enhanced cleaning aids in the control and prevention of HAI. Many studies have found that enhanced environmental cleaning ...<|separator|>
  233. [233]
    Assessing the impact of enhanced hygiene precautions during the ...
    Sep 10, 2024 · The current study aims to explore the effect of the COVID-19 pandemic on SSI incidence among initially uninfected postoperative patients.
  234. [234]
    Physical and stressful psychological impacts of prolonged personal ...
    Jun 5, 2023 · We found that hospital staff who treated patients with COVID-19 reported a high prevalence of emotional distress and serious physical ...
  235. [235]
    Prevalence of Physical and Psychological Impacts of Wearing ...
    Sep 26, 2022 · Even though PPE helps in preventing infection, it poses significant physical and psychological impacts at varying levels.
  236. [236]
    New Data Illustrate COVID-19 Pandemic Negatively Impacted ...
    Jul 14, 2022 · Infection preventionists experienced worsening mental and physical health as a result of stressors related to the COVID-19 pandemic.Missing: workers | Show results with:workers
  237. [237]
    The factors contributing to missed care and non-compliance in ...
    The aim of this study is to identify the shared factors related to both nurse non-compliance with infection prevention and control practices.
  238. [238]
    Adverse effects of isolation in hospitalised patients - PubMed
    The majority showed a negative impact on patient mental well-being and behaviour, including higher scores for depression, anxiety and anger among isolated ...
  239. [239]
    Impact of isolation on hospitalised patients who are infectious
    The review indicates that isolation to contain the risk of infection has negative consequences for segregated patients.Method · Results · Discussion
  240. [240]
    Isolation precautions are associated with higher costs, longer LOS
    Dec 22, 2017 · Bottom line: Isolation precautions are associated with higher costs and longer LOS in hospitalized general medicine patients. Citation: Tran K ...
  241. [241]
    Adverse events associated with patient isolation: a systematic ...
    Meta-analysis shows no adverse events related to clinical care or patients' experience associated with patient isolation.Review · Summary · Introduction
  242. [242]
    Impact of isolation precautions on quality of life: a meta-analysis
    Additionally, the negative impact of isolation precautions has been recognized including reduced contact with the healthcare provider, suboptimal hand hygiene ...Review · Summary · Introduction
  243. [243]
    [PDF] 21A240 Biden v. Missouri (01/13/2022) - Supreme Court
    Jan 13, 2022 · The vaccines that CMS now claims are vital had been widely available 10 months before CMS's mandate, and millions of healthcare workers had ...
  244. [244]
    Supreme Court allows CMS vaccine mandate to go into effect ...
    Jan 13, 2022 · The Court ruled 5-4 in allowing the CMS vaccine mandate to go into effect and 6-3 in blocking the OSHA mandates. AHA members will receive a ...
  245. [245]
    Are COVID-19 vaccination mandates for healthcare ... - PubMed
    Feb 15, 2024 · A systematic review of the impact of mandates on increasing vaccination, alleviating staff shortages and decreasing staff illness. Vaccine.
  246. [246]
    Impact of removing the healthcare mask mandate on hospital ...
    No evidence was found that removal of a staff/visitor mask-wearing policy had a significant effect on the rate of hospital-acquired SARS-CoV-2 infection.
  247. [247]
    The unintended consequences of COVID-19 vaccine policy - NIH
    We argue that current mandatory vaccine policies are scientifically questionable and are likely to cause more societal harm than good.
  248. [248]
    The continuing tensions between individual rights and public health ...
    Fierce battles ensued when proposals were made to mandate the reporting of people infected with HIV to public health registries, and it was not until many years ...
  249. [249]
    Congress and CDC Overreach | Mercatus Center
    Sep 9, 2022 · Though arguably well intentioned, the CDC's dictate was the most expansive invocation of the law to date and stoked a debate over emergency ...
  250. [250]
    Coronavirus disease 2019 (COVID-19) vaccination rates and ... - NIH
    The impact of jurisdiction-based mandates for vaccination against COVID-19 on HCP vaccine coverage and staffing shortages warrants assessment to inform future ...
  251. [251]
    Antibiotic Stewardship: A Decade of Progress - PMC - PubMed Central
    Antibiotic stewardship has seen transformative change over the past decade. Antibiotic stewardship infrastructure has grown significantly across the spectrum ...
  252. [252]
    Antibiotic Use and Stewardship in the United States, 2024 Update
    Nov 20, 2024 · CDC tracks antibiotic use and stewardship implementation data to evaluate progress and improve health care quality by identifying opportunities for improving ...
  253. [253]
    Effectiveness of antimicrobial stewardship programs in reducing ...
    Oct 2, 2025 · This review assesses the current evidence on the effectiveness of ASPs in influencing resistance patterns and antibiotic use in ICU settings.
  254. [254]
    U.S. FDA Approves EMBLAVEO™ (aztreonam and avibactam) for ...
    Feb 7, 2025 · In April 2024, the European Commission granted marketing authorization for EMBLAVEO® for the treatment of adult patients with cIAI, hospital- ...
  255. [255]
    WHO releases report on state of development of antibacterials
    Jun 14, 2024 · Looking at newly approved antibacterials, since 1 July 2017, 13 new antibiotics have obtained marketing authorization but only 2 represent a new ...Missing: EMA | Show results with:EMA
  256. [256]
    Bacteriophages as potential therapeutic agents in the control ... - NIH
    In addition, as of February, 2025, there are over 20 ongoing clinical trials registered in the clinicaltrials.gov database using the search terms “bacteriophage ...Missing: AMR | Show results with:AMR
  257. [257]
    Bacteriophage therapy for multidrug-resistant infections - JCI
    Mar 3, 2025 · Bacteriophage (phage) therapy has emerged as a promising solution to combat the growing crisis of multidrug-resistant (MDR) infections.
  258. [258]
    NIAID RFA: Centers for Accelerating Phage Therapy (CAPT-CEP)
    Oct 23, 2024 · The CAPT-CEPs will focus on developing preclinical assays, tools, and models for robust phage therapy R&D and advancing phage clinical research.
  259. [259]
    explainable machine learning pipeline for prediction of antimicrobial ...
    Aug 22, 2025 · We have developed a machine-learning based 2-tier pipeline to predict resistance phenotype in P. aeruginosa using only genomic sequences as ...
  260. [260]
    Prediction of antibiotic resistance from antibiotic susceptibility testing ...
    Aug 20, 2025 · In this study, we developed machine learning models to predict antimicrobial resistance using surveillance data from the Pfizer ATLAS ...
  261. [261]
    Unlocking antimicrobial resistance with multiomics and machine ...
    May 26, 2025 · Cutting-edge machine learning methods and multiomics technologies can help to combat this crisis by predicting novel AMR biomarkers and outcomes.
  262. [262]
    Machine Learning for Antimicrobial Resistance Prediction: Current ...
    May 25, 2022 · Machine learning (ML) is increasingly being used to predict resistance to different antibiotics in pathogens based on gene content and genome composition.
  263. [263]
    UV Disinfection Robots: A Review - PMC - PubMed Central
    Dec 9, 2022 · The objective of this review is to equip readers with the necessary background on UV disinfection and provide relevant discussion on various aspects of UV ...
  264. [264]
    Robotic versus manual disinfection of global priority pathogens at ...
    Jan 21, 2025 · Both robotic and manual disinfection significantly reduced the microbial load (log 2.3 to log 5.8) on hospital surfaces. No pathogens were ...
  265. [265]
    Robotic versus manual disinfection of global priority pathogens at ...
    Robotic disinfection was more effective, significantly reducing the bacterial load (log 5.8) compared to manual disinfection (log 3.95).
  266. [266]
  267. [267]
    Impact of ultraviolet light disinfection on reducing hospital ...
    UVL disinfection technologies have demonstrated potential in reducing HAIs, particularly when integrated into a comprehensive infection prevention strategy.
  268. [268]
    Artificial intelligence in hospital infection prevention: an integrative ...
    Apr 2, 2025 · AI models demonstrated high predictive accuracy for the detection, surveillance, and prevention of multiple HAIs.
  269. [269]
    Enhancing Infection Control in ICUS Through AI: A Literature Review
    Jan 7, 2025 · Real-time patient monitoring and alert systems powered by AI are shown to enhance infection detection and patient outcomes.
  270. [270]
    Enhancing Infection Control in ICUS Through AI: A Literature Review
    Jan 7, 2025 · AI enhances infection control in ICUs by predicting HAIs, real-time monitoring, automated sterilization, resource optimization, and ...
  271. [271]
    Innovative Techniques for Infection Control and Surveillance in ...
    Jan 13, 2024 · Innovative techniques for infection control and surveillance in hospital settings and long-term care facilities: a scoping review.
  272. [272]
    Antimicrobial Feature of Nanoparticles in the Antibiotic Resistance Era
    Nov 30, 2024 · In this review, the authors endeavor to comprehensively describe the antimicrobial features of NPs and their applications for different biomedical goals.
  273. [273]
    Advancements in Antimicrobial Surface Coatings Using Metal ...
    This review evaluates three principal categories of antimicrobial agents utilized in surface functionalization: metal/metaloxide nanoparticles, antibiotics, ...
  274. [274]
    Nanotechnology's frontier in combatting infectious and inflammatory ...
    Feb 21, 2024 · Nanomaterials can perform multiple bactericidal pathways, including the delivery of conventional antibiotics, interaction with cell walls or ...
  275. [275]
    Combating Healthcare-Associated Infections in Modern Hospitals
    Sep 11, 2025 · Textile Management and Antimicrobial Surfaces. Studies have also demonstrated that healthcare fabrics can harbor substantial microbial burdens.<|control11|><|separator|>
  276. [276]
    Nanomaterials for Photothermal Antimicrobial Surfaces | ACS Omega
    In this review, we will summarize the recent advances in the preparation of photothermal antibacterial surfaces.
  277. [277]
    Latest Advancements in Infection Prevention Technology
    Aug 24, 2022 · Some recent developments in IP technologies include electronic hand hygiene monitoring systems, antimicrobial textiles, ultraviolet C (UV-C) devices,
  278. [278]
    Infection Prevention: Trends and Expertise into 2025 - Galileo Search
    Nov 4, 2024 · This includes the use of ultraviolet (UV) disinfection systems, automated hand hygiene monitoring, and real-time location systems (RTLS) to ...<|separator|>
  279. [279]
    Recommendations for change in infection prevention programs and ...
    Fifty years of evolution in infection prevention and control programs have involved significant accomplishments related to clinical practices, methodologies ...
  280. [280]
    Infection Control Technologies: A Primer and Provider Selection Guide
    This white paper presents the range of infection control technologies available, their uses, and their benefits.
  281. [281]
    Progress on infection prevention and control
    May 23, 2025 · To assess the implementation of IPC measures worldwide, WHO launched a global survey in November 2023 across 150 countries, territories, and ...
  282. [282]
    Global report on infection prevention and control 2024 - ReliefWeb
    Nov 29, 2024 · The report finds that though 71% of countries now have an active IPC programme, just 6% met all of the WHO IPC minimum requirements in 2023-2024 ...
  283. [283]
    Global Antimicrobial Resistance and Use Surveillance System ...
    The goal of GAP-AMR is “to ensure, for as long as possible, continuity of successful treatment and prevention of infectious diseases with effective and safe ...
  284. [284]
  285. [285]
    Global report on infection prevention and control 2024
    Nov 29, 2024 · This second global report on IPC provides updated evidence on the harm caused to patients and health workers by HAIs and AMR.
  286. [286]
    Point prevalence survey of healthcare-associated infections and ...
    May 5, 2025 · ECDC invited EU/EEA countries to participate in one or more out of three surveillance periods: April‒June 2023, September‒November 2023 and/or ...
  287. [287]
    ECDC estimates 4.3 million patients get healthcare-associated ...
    May 6, 2024 · An estimated 4.3 million patients acquired at least one HAI per year in 2022 and 2023. Nearly a third of those HAIs (29.3%) were respiratory tract infections.
  288. [288]
    CDC: US hospitals saw declines in healthcare-associated infections ...
    Nov 7, 2024 · Overall, US acute-care hospitals in 2023 saw a 15% decline in central line-associated bloodstream infections (CLABSIs) compared with 2022, an 11 ...Missing: 2015-2023 | Show results with:2015-2023
  289. [289]
    Global antibiotic resistance surveillance report 2025
    Oct 13, 2025 · This new WHO report presents a global analysis of antibiotic resistance prevalence and trends, drawing on more than 23 million bacteriologically ...
  290. [290]
  291. [291]
    Surveillance and disease data for antimicrobial resistance - ECDC
    The Surveillance Atlas of Infectious Diseases is a tool that interacts with the latest available data about a number of infectious diseases.
  292. [292]
    on the core components for IPC - Infection prevention and control
    IPC tools and resources made available by WHO are associated with a multimodal implementation approach that integrates IPC best practices within an improved ...Missing: CDC | Show results with:CDC
  293. [293]
    CDC Disbands Infection Control Advisory Committee
    May 12, 2025 · Centers for Disease Control and Prevention (CDC) officials on March 31 disbanded the Healthcare Infection Control Practices Advisory Committee (HICPAC).
  294. [294]
    Infection Prevention and Control in Dental Settings - CDC
    A summary guide of basic infection prevention recommendations for all dental health care settings. Learn More<|separator|>
  295. [295]
    Infection Control Guidance: SARS-CoV-2 | COVID-19 - CDC
    Jun 24, 2024 · This guidance provides a framework for facilities to implement select infection prevention and control practices (e.g., universal source control) ...
  296. [296]
    Healthcare-Associated Infections: The Role of Microbial and ...
    Apr 10, 2025 · In 2016, WHO reported a prevalence rate of HAIs in low- and middle-income countries (LMIC) of 5.7–19.1%. ... HAIs caused by ESBLs is associated ...
  297. [297]
    The burden of health care-associated infection - NCBI - NIH
    In developed countries, HCAI concerns 5–15% of hospitalized patients and can affect 9–37% of those admitted to intensive care units (ICUs)., Recent studies ...
  298. [298]
    Implementation of the infection prevention and control core ...
    This study was a global situational analysis conducted across all six WHO regions to assess the implementation level of the IPC core components at the national ...Implementation Of The... · Results · Discussion
  299. [299]
    Evaluating national infection prevention and control minimum ... - NIH
    Sep 18, 2024 · Compared with the 2017–18 survey, there was a significant increase in the proportion of countries reporting an active national IPC programme (65 ...
  300. [300]
    Comparison of National Strategies to Reduce Meticillin-Resistant ...
    Findings: In England significant reduction has been achieved in number of reported MRSA bloodstream infections. In Japan, in spite of reductions, MRSA remains a ...
  301. [301]
    Hand hygiene improvement of individual healthcare workers: results ...
    Oct 5, 2022 · Overall, pooled HH compliance increased from 43.1 to 58.7%. The proportion of improving HCWs ranged from 33 to 95% among ICUs.<|separator|>
  302. [302]
    Communicating the Risk of MRSA: The Role of Clinical Practice ...
    This article aims to provide an overview of the different approaches to the control of MRSA adopted in five European countries (Austria, Germany, Netherlands, ...
  303. [303]
    MRSA infection rates by country - One Health Trust
    In Europe, only Romania and Malta had higher rates of MRSA than the United States in that year. MRSA levels were high in East Asia, specifically South Korea, ...
  304. [304]
    Infection prevention and control policies in hospitals and prevalence ...
    Dec 6, 2022 · There are differences in infection prevention and control (IPC) policies to prevent transmission of highly resistant microorganisms (HRMO).Data Collection · General Ipc Measures · Author Information
  305. [305]
    Credentialling in Australia for infection prevention and control
    Sep 13, 2024 · In this paper, we detail the history and evolution of credentialling of the infection control professionals in Australia.
  306. [306]
    [PDF] Evaluation of the Infection Prevention and Control Nurse Lead role ...
    The evaluation assessed the introduction of the IPC Lead role on IPC capability in residential aged care homes with a focus on: • implementation. • perceived ...
  307. [307]
    Policy implementation for methicillin-resistant Staphylococcus ...
    Jul 26, 2017 · We also compared the difference in MRSA proportion between countries with and without MRSA mandatory surveillance policies. The rate of ...
  308. [308]
    Progress to bring MRSA under control worldwide - Healio
    Jun 1, 2011 · There is a great variation between countries regarding the burden of MRSA. In Scandinavia, for example, they have much better policies for using ...